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Chapter I 
INTRODUCTION AND OUTLINE 
OF INVESTIGATION 
11 

The herododegenerativc neurological disorders present a large collection of clini-
cally progressive conditions for which no satisfying scheme of classification is 
available at present. This lack of proper classification mainly reflects the poor 
state of present knowledge regarding the specific mechanisms underlying these 
disorders. Pathologically these conditions are characterized by intrinsic or 'pri-
mary' degeneration of cells or cell systems in various parts of the central and/or 
peripheral nervous system. The term 'degeneration' refers to a pathologic process 
of 'deforming, rarefying and degradating changes which lead ultimately via 
necrobiosis to the disintegration and loss of the affected structures' (definition 
by Seitelberger, 1975). Since most of the primar)' degenerative disorders have a 
clear genetic basis or at least a tendency to familial occurrence, the entire group 
is usually referred to as 'heredodegenerative'. 
With the specific underlying defects in many conditions unclarified, diagno-
sis and classification of the heredodegenerative disorders still depends largely 
upon clinico-genetic and histopathological criteria. In clinical practice, this 
dependence on pathological criteria will often lead to great diagnostic difficulty 
as adequate information about the precise nature and distribution of the under-
lying pathological alterations is usually lacking. In disorders with prominent or 
exclusive involvement of the peripheral nervous system (PNS) this problem can 
in many cases be solved quite satisfactorily by performance of peripheral nerve 
biopsy, a procedure the usefulness of which for diagnosis and classification of 
such disorders has received extensive documentation in various textbooks (e.g. 
Dyck et al. 1984). In disorders with prominent or exclusive involvement of the 
central nervous system (CNS), however, the usefulness of this procedure has 
received much less attention. Extensive biopsy data appear available only in a 
small number of well-known conditions (such as Friedreich's ataxia) and no sys-
tematic information can be found as to the contribution which biopsy can 
provide to the diagnosis and classification of CNS degenerations. In addition, no 
systematic data are available as to the contribution biopsy may provide in 
improving our insight into the pathology and the pathophysiology of these 
disorders. 
In history the first successful application of nerve biopsy in heredodegenerati-
ve disorders of the CNS was reported in 1959, when Thieffry and Lyon demon-
strated that this procedure was helpful in the diagnosis of metachromatic leuko-
dystrophy. In subsequent years the procedure was demonstrated to be useful in 
various other conditions as well (Schwartz et al. 1963, Lambert and Dyck 1968, 
McLeod 1969, Bischoff and Ulrich 1969), and at the end of the nineteen-sixties 
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nerve biopsy had become a well-established method of investigation which pro-
mised to be fruitful in a variety of conditions and which appeared virtually never 
to cause important residual complaints (Thomas 1970). 
Between 1970 and (approximately) 1975 the interest in nerve biopsy as an aid 
in the diagnosis of heredodegenerative disorders of the CNS was particularly 
vivid, as illustrated by the appearance of numerous case reports documenting 
peripheral nerve involvement in patients suffering from diseases like Cockayne 
syndrome (Moosa and Dubowitz 1970), neuroaxonal dystrophy (Duncan 1970), 
Batten's disease (Carpenter et al. 1972), familial extrapyramidal disease with neu-
ropathy (Ziegler et al. 1972), adrenoleukodystrophy (Schaumburg et al. 1975), 
Niemann-Pick disease (Gumbinas et al. 1975), Werdnig-Hoffmann disease (Car-
penter et al. 1975) and amyotrophic lateral sclerosis (Dyck et al. 1975). 
After this period, however, the role of nerve biopsy in the evaluation of CNS 
degenerations began to decline gradually as a result of new developments in the 
diagnostic approach, such as the introduction of specific enzyme assays (for 
example in metachromatic leukodystrophy and in globoid cell leukodystrophy), 
the increased use of alternative biopsy procedures such as skin or conjunctival 
biopsy (particularly in storage disorders: Carpenter et al. 1972, O'Brien et al. 
1975, Dolman et al. 1975, Martin and Ceuterick 1978, Arsenio-Nunes et al. 
1981, Ceuterick and Martin 1984), and the development of more sophisticated 
electrodiagnostic equipment enabling better clinical evaluation of peripheral ner-
ve function (Notermans 1984). 
Owing to these various developments the indications for nerve biopsy in the 
heredodegenerative disorders of the CNS seem to have become rather few. 
Unfortunately, however, no systematic information can be found in the literatu-
re concerning the indications for the procedure which may have remained. Even 
in standard textbooks (e.g. Dyck et al. 1984) these indications have received no 
detailed attention and no practical guideline has ever been offered. 
This formed the starting point of our present investigation, in which we 
want to analyze the following three questions: 
A. What is the contribution of peripheral nerve biopsy (sural nerve) to the diag-
nosis and classification of heredodegenerative disorders of the CNS? 
B. Does nerve biopsy provide further insight into the pathology and patho-
physiology of these disorders? 
C. What are the current indications for the procedure? 
In order to analyze these questions we have made a retrospective study of sural 
nerve biopsies of all patients with CNS degenerations who were biopsied in Nij-
14 
megen (Interdisciplinaire Werkgroep Neuromusculaire Aandoeningen) during 
the period 1970-1982 The biopsy findings in these patients were evaluated with 
regard to their contribution to diagnosis and classification, and also with regard 
to their contribution to providing an insight into the pathology and pathophy-
siology of the underlying disorders In addition, the findings were evaluated 
with respect to currently used procedures in the diagnostic approach, in order to 
analyze the indications for biopsy which may have remained 
In the next chapters we shall present the results of our study and, on basis of 
the findings obtained, we shall discuss the value of nerve biopsy in patients with 
CNS degenerations 
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PATIENTS AND METHODS 
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SELECTION AND CLASSIFICATION OF PATIENTS 
For the present analysis we have studied 176 patients suffering from a variety of 
CNS degenerations. These patients were selected from a large group of over 800 
patients, who had been biopsied since 1970 in Nijmegen (Interdisciplinaire 
Werkgroep Neuromusculaire Aandoeningen) for a large variety of degenerative 
and nondegenerative neurologic diseases. The primary selection of patients for 
our study was based upon a screening of the diagnosis records of the Werk-
groep. For further selection the clinical, electrodiagnostic and histopathological 
records were studied, and follow-up date (if relevant) were obtained. In order to 
facilitate analysis, the data of each patient were summarized on standard registra-
tion forms (for model: see Addendum). Final selection for the present study 
in all cases was based upon the final diagnosis, irrespective of how or when this 
diagnosis was obtained (for example: nerve biopsy, biochemical assay, family 
analysis or eventual autopsy). 
For purposes of evaluation the patients were subdivided into 6 major clinical 
categories (Table 1). Evaluation per category rather than evaluation per distinct 
disease entity was chosen, as the numbers of biopsied patients per entity were 
usually too low to permit valid analysis. The results were elaborated in the form 
of 6 survey studies (each covering one major category: see chapter III 1-6), in 
addition to 5 studies of relevant case observations, illustrating the diagnostic 
role of biopsy in metachromatic leukodystrophy (II 1.1), the usefulness of biop-
sy in documenting peripheral neuropathy in an atypical case of globoid cell leu-
kodystrophy (II 1.2), the value of biopsy in clarifying the features of neuropathy 
in Cockayne syndrome (II 1.3), the role of biopsy in the diagnosis of adult 
Table 1. Survev of biopsied patients (period 1970-1982) 
Citegorv No 
Diffuse cerebral degenerative disorders (children) 82 
Diffuse cerebral degenerative disorders (adults) 10 
IIcrcditar\ ataxias and spastic paraplegias 36 
flereditan motor neuropathies 18 
Motor neuron disease 10 
Heredodegenerative extrapyramidal disorders 20 
19 
Table 2. Annual numbers of sural nerve biopsies in patients with heredodegcnerative disorders 
of the central nervous s\stcm (period \9~O-1982) 
Year 
1970 
1971 
1972 
1973 
1974 
1975 
1976 
1977 
1978 
1979 
1980 
1981 
1982 
Total 
Diffuse cerebral 
degenerative 
disorders 
(children) 
3 
7 
15 
11 
7 
10 
8 
4 
4 
4 
•> 
2 
2 
82 
(adults) 
0 
0 
2 
0 
0 
0 
0 
3 
2 
0 
1 
0 
2 
10 
Hereditan 
ataxias 
and spastic 
paraplegias 
5 
4 
6 
1 
2 
Í 
3 
4 
1 
1 
1 
3 
1 
36 
Hcreditar\ 
motor 
neuropatln 
1 
2 
2 
0 
2 
2 
2 
1 
2 
1 
0 
1 
2 
18 
Motor 
neuron 
disease 
0 
1 
2 
1 
0 
1 
1 
1 
2 
0 
0 
0 
1 
10 
Heredode-
generativc 
extrapyramidal 
disorders 
0 
1 
4 
2 
1 
3 
0 
1 
2 
1 
1 
1 
0 
20 
Total 
9 
18 
31 
15 
12 
20 
14 
14 
13 
7 
8 
7 
8 
1^6 
polyglucosan body disease (II 2.1) and the value of biopsy in clarifying the 
mechanism of peripheral nerve involvement in cerebrotendinous xanthomatosis 
(II 2.2). 
Since this is a retrospective study, the material presented is obviously not illu-
strative of our current use of the procedure, as the indications naturally became 
modified by growing experience with biopsy, and by new developments and 
changing views in the diagnostic approach. This process is reflected in a marked 
change in the annual numbers of biopsies during the studied period (Table 2 
and Figure), showing a clear maximum in the first years after the introduction 
of the procedure, followed by steady decrease in subsequent years. 
ELECTRONEUROMYOGRAPHIC DATA 
The electroneuromyographic investigations were performed at the Department 
20 
No of biopsies 
4 0 - , 
3 0 -
2 0 -
1 0 -
70 75 80 year 
Figure. Graphic presentation of annual numbers of sural nerve biopsies in the period ¡970-1982. 
of Clinical Neurophysiology of the Institute of Neurology of the Radboud Uni-
versity Hospital. 
The neurographic measurements were made on a routine basis, using conven-
tional procedures with surface stimulation and recording. The standard program 
included measurements of at least one motor nerve (usually the peroneal nerve), 
evaluation of the Hoffmann reflexes and, particularly in later years of the stu-
died period, measurement of the sensory nerve action potentials. For adults, the 
reference values of the department have recently been described by Van Wensen 
(1980). Reference values for nerve conduction in children were derived from the 
papers of Thomas and Lambert (I960), Gamstorp (1963), Baer and Johnson 
(1965), Radtke (1969), and Wagner and Buchthal (1972). 
Electromyographic examinations were performed with conventional concen-
tric needle electrodes. In most patients, at least one distal and one proximal ske-
letal muscle were examined. 
21 
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HISTOPATHOLOGICAL METHODS 
Sural nerve specimens in all patients were obtained by whole nerve biopsy at 
midcalf level. In children this procedure required general anaesthesia; in older 
patients, the biopsies could be performed under local anaesthesia. All biopsies 
were performed in the Institute of Neurosurgery (head: Prof. Dr. H. A D. Wäl-
der) of the Radboud University Hospital. 
Obtained specimens were processed and examined in the Research Laboratory 
for Morphologic Neurology of the Institute of Neurology and in the Institute 
of Submicroscopic Morphology of the Radboud University Hospital. Microsco-
pic examination of the specimens in all cases was performed by Mrs. Drs. 
AAWM Gabreëls-Festen (light microscopy) and Dr. EMG Joosten (electron 
microscopy). 
Light microscopica/ techniques 
Cryostat sections were stained with hematoxylin and eosin (HE), toluidine blue, 
Sudan III and IV, Sudan Black B, cresyl violet (Von Hirsch-Pfciffer) and perio-
dic acid-Schiff (PAS). 
Activities of the following en7vmes were investigated: lactate dehydrogenase, 
NADH-tetrazolium-oxido-reductase, a-glucose-6-phosphate dehydrogenase and 
acid phosphatase. 
Paraffin sections were used for Bodian silver impregnation. 
For teased fiber preparations, one fascicle of 8 mm was fixed in 29c calcium 
chloride and 4% formaldehyde and postfixcd in 1% osmium tetroxide in 0.1 M 
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phosphate buffer pH 7.4. From each nerve approximately 25 teased fibers were 
obtained and evaluated with regard to occurrence of various pathological featu­
res, including paranodal or segmental de- and remyelination, and axonal 
degeneration with linear rows of myelin balls (method of grading described by 
Stevens et al. 1973). Semithin sections, obtained from material prepared for elec­
tron microscopy (see below), were stained with toluidine blue for light micro­
scopical examination. 
Electron microscopical techniques 
Material for electron microscopy was fixed in 2% glutaraldehyde buffered with 
sodium cacodylate pH 7.4, postfixed in 2% osmium tctroxide in Palade buffer 
pH 7.4 and, after dehydration in alcohol, embedded in Epon 812. Ultrathin sec­
tions were stained with uranyl acetate and lead citrate. 
For quantitative data, eight electron micrographs (16 χ 16 cm) of various fas­
ciculi were enlarged to a final magnification of 1710 χ for counting and measu­
ring of myelinated fibers. Density of these fibers and frequency distribution of 
their diameters (histogram) were determined with the help of a Zeiss-TGZ-3 
particle size analyzer. For counting of unmyelinated fibers, 2 x 2 exposures (final 
magnification 3170 x) of two fasciculi were used. The total transverse fascicular 
area (TTFA) was determined with the aid of a planimeter on photographic 
enlargements of semithin transverse sections of the nerve. 
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Ill 1 
SURAL NERVE BIOPSY IN THE DIAGNOSIS 
OF DIFFUSE 
CEREBRAL DEGENERATIVE DISORDERS 
OF CHILDHOOD 
27 
ABSTRACT 
A retrospective study of sural nerve biopsies in 82 children with diffuse cerebral 
degeneration is presented. The indications for the procedure are discussed in rela-
tion to current diagnostic views. It is concluded that biopsy is still useful only in 
occasional patients with associated peripheral neuropathy. In patients without 
neuropathy there is no current indication for biopsy at all. 
28 
INTRODUCTION 
Biopsy investigations still play an important role in the diagnosis of diffuse cere­
bral degenerative disorders of childhood Especially in those conditions in which 
a specific enzyme defect has not yet been demonstrated, diagnosis often still 
depends on biopsy. One of the procedures traditionally used in this respect is 
peripheral nerve biopsy. In recent years, however, the indications for this proce­
dure seem to have become few, since excellent results have been obtained with 
less invasive investigations like skin or conjunctival biopsy (Carpenter et al. 
1972; O'Brien et al. 1975; Dolman et al. 1975; Martin and Ceuterick 1978; Arse-
nio-Nunes et al. 1981; Ceuterick and Martin 1984). 
In the current paper (which is a modified and extended version of a previous 
communication: Vos et al. 1982a) we present a retrospective view of our perso­
nal experience with nerve biopsy in the diagnosis of such disorders, and discuss 
the indications that may have remained. 
PERSONAL OBSERVATIONS 
Since 1970 we have performed sural nerve biopsies in 82 children with diffuse 
cerebral degeneration. The specimens were taken at midcalf level, and processed 
according to methods previously described Qoosten et al. 1974). 
The diagnostic contribution for our entire series is shown in Table 1, while 
the findings in the individual cases are presented in Table 2 (children with clini­
cal evidence of involvement of the peripheral nerves in the disease process) and 
Table 3 (children without clinical neuropathy). Of course, since this is a retro­
spective view, the material presented does not reflect our current use of the 
procedure. 
Table I. Dugnosuc contribution of sutal nerve biops\ in 82 cases 
Number Diagnostic contribution of the biops\ 
of 
cases Positive Negative 
Cases with clinical neuropath\ 26 2} (8ЯЯ-) } (12%) 
Cases without neuropathv 56 2^ (48%) 29 (52%) 
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Table 2 Sural nerve biopsv findings in 26 cases with clinical neuropath\ 
Diagnosis N o Biops\ findings 
Diagnostic 
contribution 
of the biops\ 
Metachromatic leukod\stroph\ 
late infantile onset 
earh iuvenile onset 
late juvenile onset 
Austin variant 
Globoid cell leukodvstrophv 
typical infantile cases 
atypical infantile case 
Cockayne syndrome 
Juvenile Batten's disease 
San Filippo disease 
Juvenile I eigh's disease 
proved case (autops\ ) 
presumptive case 
Juvenile Alpers' syndrome 
6 deposits, segmental dermehnation 
deposits, segmental dem\elinanon 
deposits, no significant dermelinanon 
deposits, segmental dermehnation 
deposits, segmental demyelmation 
deposits, no significant dermehnation 
deposits, segmental dermehnarion 
deposits, loss of thick fibers 
deposits, mild axonal degeneration 
active axonal degeneration 
mild chronic axonal neuropathy 
mild axonal de and regeneration 
+ 
+ 
+ 
+ 
+ 
Table 3. Sural nerve biopsy findings in 56 cases without clinical neuropath\ 
Diagnostic 
contribution 
of the biopsv Diagnosis N o Biopsv findings 
Batten's disease 
late infantile onset 8 
juvenile onset 17 
San Filippo disease 2 
Lafora's myoclonus epilepsy* 
Sudanophihc leukodvstrophv* 
Infantile Alpers' syndrome* 
Leigh's disease* 
late infantile onset 
juvenile onset 
Central dysmyelmanon syndrome* 
Menkes disease 
Zellweger's syndrome* 
Kearns-Shy syndrome 
No definite diagnosis 18 
deposits in 7 cases only (one case* missed) 
deposits in all cases 
deposits in both cases 
polvglucosan bodies 
normal 
slight axonal degeneration 
normal 
slight axonal degeneration 
normal 
normal 
normal 
normal 
normal in 15 cases, slight 
axonal degeneration in 3 
4-
+ 
+ 
+ 
* definite diagnosis established on later occasion (bum biopsv or autopsv ) 
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In the 26 patients with clinical neuropathy (Table 2) the diagnostic contribu-
tion of the biopsy was positive in 23 cases (88%). 
In the 9 patients with metachromatic leukodystrophy (including one child 
with the Austin-variant) the biopsy findings consisted of sulphatide deposits 
(Figures 1 and 2), in combination with segmental de- and remyelination. The 
latter feature was usually prominent, except in the late juvenile case in which 
no significant demyelination was found (the child had low distal tendon jerks 
and distal amyotrophy, but near-normal nerve conduction). 
In the 3 typical infantile cases of globoid cell leukodystrophy, the findings 
consisted of specific deposits in combination with widespread segmental de- and 
remyelination (Figures 3 and 4). In an atypical infantile case, specific deposits 
were found but no significant demyelination (this infant had low distal tendon 
jerks, but normal nerve conduction). 
In the 6 patients with Cockayne syndrome, typical deposits (Figure 5) were 
found in combination with segmental de- and remyelination of varying severity. 
In the 3 patients with juvenile Batten's disease, typical deposits (Figure 6) 
were observed in combination with slight loss of large myelinated fibers. All 
three suffered from longstanding disease, and all three were on anticonvulsant 
therapy. 
Fig. 1 Déposition of storage material in metachromatic leukodystrophy. Acid phosphatase stam, χ} 50. 
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Fig. 2. So-called 'tuffstone bodies' in a Schwann cell, typicalh wn ¡n metachromatic leukodystrophy. x}9.000. 
In the patient with San Filippo disease the findings consisted of mucopoly-
saccharide deposits (Figure 7) combined with mild axonal degeneration. 
No significant diagnostic contribution was obtained in the 2 patients with 
juvenile Leigh's disease and in the one with juvenile Alpcrs' syndrome. Biopsies 
in these patients showed axonal degeneration, without any specific diagnostic 
features. 
In the 56 children without clinical neuropathy (Table 3) a positive diagnostic 
contribution was obtained in 24 out of 25 cases of Batten's disease, in 2 patients 
with San Filippo disease and in one patient with Lafora's myoclonus epilepsy. 
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Fig. 3· Typical deposits (D) in a Schwann ce// surrounding a dmyelinated axon (A). Globoid cell leukodystroph) 
хОб.ООО. 
In Batten's disease the biopsy appeared particularly reliable in the juvenile 
form (all 17 biopsies positive). In the late infantile form, typical deposits (Figure 
8) were found in 7 cases while in one case the diagnosis was missed (error 
brought to light at autopsy). 
In the patient with Lafora's myclonus epilepsy a few small polyglucosan 
bodies (Lafora bodies) were found in the biopsy specimen. Examination of sweat 
gland duct cells in an axillar skin biopsy specimen, however, revealed these 
bodies much more impressively. 
The slight axonal degeneration in the infantile case of Alpers' syndrome and 
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Fig. 4. Loi* magnification showing several demyetinaled (closed arrows) or remyelinated (open arrows) fibers. Typi 
cai infantile globoid cell leukodystroph). xl .2 50. 
in the juvenile case of Leigh's disease was clinically inapparent. 
In 18 children without clinical neuropathy, no definite diagnosis could be 
made. Nerve biopsy in this group was normal in 15 cases, while slight axonal 
degeneration was found in the remaining three. 
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Fig. 7. Mtmhrane-hound mucopolysaccharide deposits fasterixj in a Remak ce/ί containing tuo unmyelinated axons 
(Λ). San Filippo disease. X29.600. 
DISCUSSION 
The question to be discussed here is whether peripheral nerve biopsy is still 
valuable in the diagnosis of diffuse cerebral degenerative disorders in children. 
Two categories of patients will be discussed: those who show clinical evidence 
of involvement of the peripheral nerves in the disease process, and those who do 
not. 
In children with clinical neuropathy, biopsy has been used quite successfully 
in the past. As our material illustrates (Table 2), a positive diagnostic contribu­
tion can be obtained in the large majority of such cases. Owing to recent dcvel-
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Fig. 8. Curvilinear cüpoutiim mali rial, typical of late infantile Batten'i disease. X98.000. 
opments, however, the indications for biopsy in this category of patients have 
become very few. This is evident from Table 4, which shows that diagnosis is 
now usually obtainable in a less invasive way. In view of this the current use of 
the procedure should obviously be limited to patients in whom less invasive 
tests have failed to establish a definite diagnosis. Except for the possibility of a 
new disease entity, the differential diagnosis in such patients (who will be rare) 
includes Leigh's disease, Alpers' syndrome (which is probably related to defective 
pyruvate metabolism; Prick et al. 1981) and, if there is also ophthalmoplegia, 
'oculocraniosomatic disease'. As shown by the table, little diagnostic help is to be 
expected from nerve biopsy in the latter three conditions, but more date are 
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Table 4. Diagnostic contribution oí nerve hiops\ in cases with clinical neuropatia 
Diagnosis 
Diagnostic contribution 
of nerve biops\ 
Current diagnostic approach in 
conditions where positive nerve 
biopsies have been obtained 
Metachromatic leukod\stropln + (Thieftrv and L\on 1959) 
+ (Bischoffand Ulrich 1969) Infantile globoid cell 
lcukod\stroph\ 
Cotka\ne svndrome 
Juvenile Batten's disease 
San Filippo disease 
Niemann-Pick s\ndromc (t\pc A) + (Gumbinas et al 19^5) 
Adrenoleukod\ stroph\ 
enz\me assa\ 
enz\me assa\ 
+ (Moosa and Dubowitz 197()) skin biops\ 
(Smickelet al 19^) 
+ (present stud\ Table 2) 
Generalized giant axonal 
neuropathy 
Chediak-Higashi s\ndrome 
Leigh's disease 
Alpers' syndrome 
'Oculocramosomatic disease' 
+ (present stud\ Table 2) 
7 
4 (Domagket al I975) 
+ (Asbun et al 19"2) 
+ (Lockman et al 196"7) 
- (Moosa W*)) 
- (present stucK Table 2) 
- (Sin et al 1967)* 
skin biops\ 
(Carpenter et al 1972) 
en/\ me assa\ 
en / \me assa\ 
skin biops\ 
(Mar t ine ta l 1980) 
skin biops\ 
(Takebcetal 1981) 
examination of blood smear 
* eight \cars after the hiops\ nerve conducnon in this pinuit had returned to normalfBeanhcrg et il 19""') 
certainly needed to support this view. If the clinical features, however, suggest 
that the child may be suffering from a new disease entity, a plain indication for 
nerve biopsy is presented, as the procedure may reveal unusual pathological 
features distinct enough to suggest that a new entity is indeed being dealt with. 
Occasionally we still use biopsy in the diagnosis of metachromatic leukodys-
trophy since low arylsulphatase A activity, found in a patient with clinical neuro-
pathy, may fail to discriminate between the homozygote and heterozygote state 
(Vos et al. 1982b: see chapter III 1.1 of the present thesis). Also, on rare occa-
sion, we use biopsy for documentation of peripheral nerve involvement it-
self, as we did for instance in a juvenile case of metachromatic leukodystrophy 
and in an atypical case of globoid cell leukodystrophy (Vos et al. 1983; see chap-
ter III 1.2). In both cases, where the absence of markedly reduced nerve conduc-
tion did cast considerable doubt on the enzymatic diagnosis, the biopsy revealed 
characteristic deposits (confirming the diagnosis) but no sifnificant demyelina-
tion (which explains the electrodiagnostic findings). In our patients with Coc-
kayne syndrome the main purpose of the biopsies was to document that segmen-
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Table 5. Diagnostic contribution of nerve biops\ in cases without clinical neuropathn 
Diagnosis 
Diagnostic contribution 
of nerve biopsy 
Current diagnostic approach in 
conditions where positive nerve 
biopsies have been obtained 
Batten's disease 
Lafora's myoclonus epilepsy 
Hunter syndrome 
Adrenoleukodv trophv 
Fucosidosis 
Neuraxonal dystrophy 
Canavan's disease 
Alexander's disease 
Oculocramosomatic disease 
Late onset globoid cell 
leukodystrophy 
Alpers' syndrome 
Leigh's disease 
Central dysmyelination 
syndrome 
Menkes' disease 
Zellweger's syndrome 
+ (Carpenter et al 1972)* 
+ (present study Table 3)* 
+ (Swift and McDonald 1976) 
+ (Schaumburgetal 1975)* 
+ (Trooster al 1977) 
+ (Duncan et al 1970)* 
- (Adornato et al 1972) 
- (Fscourollc et al 1979)* * 
- (Herenberg et al 1977) 
- (Crome et al 1973) 
- (present study Tabic 3) 
- (present study) 
- (present study) 
- (present study) 
- (present study ) 
skin biopsy 
(Carpenter et al 1972) 
skin biopsy 
(Carpenter and Karpati 1981) 
en¿yme assay 
skin or conjunctival biopsy 
(Martin et al 1980) 
en7ymc assay 
skin or conjunctival biopsy 
(Aicardi and Castelein 1979) 
* negative biopsies have jlso occurred in these conditions 
* * reported abnormalities unlikely to be of much diagnostic help 
tal demyelination of the peripheral nerves is a quite constant feature in this con-
dition. Surprisingly, the biopsies in these patients also revealed occurrence of 
typical deposits which may have specific diagnostic significance and which could 
be evidence of a lysosomal storage disease (Vos et al. 1983: see chapter III 1 3) 
The diagnostic contribution of biopsy in cases without clinical neuropathy is 
shown in Table 5. The conclusion from this table is that the procedure has beco-
me entirely unnecessary in this category of patients, since less invasive ways of 
making the diagnosis are now available in all conditions where positive biopsies 
have been obtained in the past. This conclusion is not challenged by our own 
data (Table 3), as positive biopsies were obtained only in conditions where 
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the diagnosis is now preferably made by means of other tests In view of this, 
and in view of the fact that in over half of our cases without neuropathy 
the diagnostic contribution of the biopsy was entirely negative (Table 1), we 
suggest that performance of nerve biopsy in children with diffuse cerebral dege­
neration but no clinical features of neuropathy should be totally abandoned 
Our general conclusion is that the current indications for peripheral nerve 
biopsy in the diagnosis of diffuse cerebral degenerative disorders of childhood 
are limited to occasional patients with associated clinical neuropathy In cases 
without neuropathy there is no current indication for biopsy 
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ABSTRACT 
The value of sural nerve biopsy in the diagnosis of metachromatic leucodystro-
phy (MLD) was studied in 9 MLD-patients and 4 other patients with low aryl-
sulphatase A (ASA)-activities in the leucocytes. In 7 patients (5 of them suf-
fering from MLD) adequate interpretation of low ASA-activity was impossible, 
either because one of the parents also had low ASA-activity or because the obli-
gatory information about the ASA-activity of the parents could not be obtained. 
In these cases sural nerve biopsy provided essential diagnostic information, cor-
rection one false negative and two false positive diagnoses of clinical MLD. 
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INTRODUCTION 
In the majority of patients suffering from metachromatic leucodystrophy 
(MLD) a solid basis for the diagnosis is found in the combination of clinical 
signs compatible with MLD, low arylsulphatase A (ASA)-activity in the leucocy-
tes, marked reduction of nerve conduction velocities and elevated cerebrospinal 
fluid (CSF) protein level. However, adequate interpretation of low ASA-activity 
may be difficult because there is a considerable overlap of enzyme activity 
between MLD-patients and MLD-carriers: low ASA-activity also can be found in 
persons not having MLD (Lott et al. 1976, Dubois et al. 1975, 1977), while mis-
leadingly high ASA-activities do occur in some MLD-patients (Turpin et al. 
1974, Kihara 1976, Aleck et al. 1977, Bosch and Hart 1978). A more reliable 
interpretation of low leucocyte-ASA-activity in a child is feasible when the enzy-
me activities of the parents are known. If both parents have ASA-activities clear-
ly in the range of heterozygotes, low ASA-activity in their child is consistent 
with homozygote MLD. However, if low ASA-activity occurs in one of the 
parents, low ASA-activity in the child does not prove homozygote MLD 
(Dubois et al. 1975, 1977). 
The aim of this paper is to demonstrate that sural nerve biopsy, although 
perhaps questionable as a routine-procedure in the diagnosis of MLD, can provi-
de essential diagnostic information when adequate interpretation of low ASA-
activity is impossible. 
MATERIAL AND METHODS 
Table 1 summarizes the relevant data of 9 MLD-paticnts (cases 1-6, 9, 17 and 20) and 4 other 
patients with low leucocvte-ASA-acrivities (cases 12, 13, 21 and 22) Sural nerve biopsy was per-
formed in all these cases To show the cn¿vmatic overlap, 9 asymptomatic persons with low 
ASA-activitv (cases 7. 8, 10, 11, 14, 15. 16, 18 and 19) are added to Table 1 although none of 
them underwent sural nerve biopsy These asymptomatic persons arc relatives of our MLD-
patients no 6, 9, I7 and 20 
The ASA-assav in the leucocytes and the preparation of the biopsy specimens were performed 
in the same way as described in our previous reports on the subject of MLD (Gabreels et al 
1971,Joostenet al 1975) 
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Table 1. Relevant data of 22 persons with low leucocyte ASA activities Arrangement of the table according to the levels of ASA 
activity Diagnosis before and after sural nerve biopsy (if performed) is indicated 
Case ASA' Clinical data 
Diagnosis before 
M N C V ' CSF' sural nerve biopsy 
Diagnosis after 
sural nerve biopsy 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
1 
1 
1 
2 
2 
4 
4 
5 
5 
5 
5 
5 
6 
6 
6 
6 
6 
7 
8 
8 
9 
12 
Psvchomotor regression + peripheral neuropathy 
Psychomotor regression + peripheral neuropathy 
Psychomotor regression + peripheral neuropathy 
Psychomotor regression + peripheral neuropathy 
Ps)chomotor regression + peripheral neuropathy 
Psychomotor regression + peripheral neuropathy 
N o symptoms (younger sib of case 6) 
No symptoms (older sib of case 17) 
Mental regression + peripheral neuropathy 
N o symptoms (father of case 17) 
N o symptoms (mother of case 6) 
Pyramidal signs, convulsion 
Progressive neuropathy + pyramidal signs 
N o symptoms (non-identical twin of case I 7 ) 
No symptoms (mother of case 9) 
No symptoms (older sib of case 9) 
Psvchomotor regression + neuropathy 
N o symptoms (older sib of case 9) 
No symptoms (mother of case 20) 
Progressive neuropathy 
Psychiatric signs, djskinesia 
Progressive neuropathy 
44 
46 
50 
67 
68 
41 
+ 
+ 
+ 
+ 
+ 
42 
34 
N 
100 
90 
100 
N 
N 
17 
52 
40 
+ 
N 
Late infantile MLD 
Late infantile MLD 
Adult MLD 
Late infantile MLD 
Late infantile MLD 
Late infantile MLD 
Preclinical MLD-1 
Probably MLD-hetcro/)gote 
Adult MLD 
Obligate MLD-hetero/vgotc 
Obligate MLD-heteio/ygote 
Clinical MLD 3 
Adult MLD 
Preclinical MLD 3 
Obligate MLD-hetero¿)gote 
Probably MLD-hettrozygote 
Juvenile MLD 5 
Probably MLD-hctero¿ygote 
Obligate MLD-hetcro/ygote 
HMSN type 1 
Adult MLD 
HMSN type 1 
Late infantile MLD 
Late infantile MLD 
Adult MLD 
Late infantile MLD 
Late infantile MLD 
Late infantile MLD 
No biopsy done 
N o biopsy done 
Adult MLD 
No biopsy done 
No biopsy done 
Preclinical MLD5 
No clinical MLD 
No biopsy done-
No biopsy done 
No biopsy done 
Juvenile MLD 
N o biopsy done 
N o biopsy done 
Late infantile MLD 
No clinical MLD 
HMSN type 1 
1
 ASA Arylsulphjusc A activity in leucocytes (nmol/mg of prorun/hr) Control values (n = 6'>S) mean ""1, SD 21 5 Obligatory hctiro/ygotcs 
(n = Y)) mean 30, SD 15 range 1 67 MI D patients (n = 25) mean 2 59, SD 2 11 range 0 8 
MNCV mean nerve conduction veloeity (9f of mean control) 
' ( SI· eerebrospinal fluid protein level N normal + elevated 
CASE REPORTS 
9 MI D-cases 
This group consists of six late infantile, one juvenile and two adult cases Signs of a progressi\c 
diffuse white matter disease were present in 5 late infantile cases (no 1, 2, 4, 5 and 6) and in the 
juvenile case (no l"") Mental regression and gait disturbances were the outstanding svmptoms 
in the two adult cases (no Ь and 9) Elcctroneurographic examination in all cases revealed a 
marked reduction of nerve conduction velocities consistent with demvelinating neuropathy 
CSF-protein levels were elevated in all cases examined, only in one adult case (no 9) a normal 
level was found The lcucoc\te-ASA-activities in all cases were low 
Puzzling diagnostic problems emerged in one child (no 20) This patient was admitted with 
progressive peripheral neuropathy of late infantile onset No signs of cerebral involvement were 
manifest The nerve conduction velocities were in the range of demyclinating neuropathy The 
CSF protein level was markedly elevated The leucocyte-ASA-activity was low, but considerably 
above the level we were used to find in MLD Therefore, homo/ygote MLD was considered to 
be excluded and a sporadic form of hypertrophic Charcot-Mane-Tooth disease (hereditan motor 
and sensory neuropathy type I HMSN type I, Dyck 19~")) was diagnosed 
Sural nerve biopsy specimens in all 9 cases showed massive accumulation of metachromatic 
material in Schwann cells and in macrophages In case no 20 this massive accumulation of 
sulphatides was a totally unexpected finding, which established MLD Acid phosphatase-activity 
invariably was stiongly increased with about the same distribution as the mctachromasia I'ltra-
structurally, the accumulated material showed the configurations which are considered to be 
more or less specific of sulphatides Teased fiber studies in 5 patients showed very active segmen­
tal demyclination in ^ late infantile cases but hardly any segmental de- or remyelinanon in the 
two adult patients Ultrastructurally active segmental demyclination with some onion bulb 
formation was found in all late infantile cases and in the juvenile case In both adult cases, 
howeyer, much less active demyclination occurred, some onion bulb formation was only seen in 
one of the two 
4 cases with low leucocyte-ASA-activity, not having clinical MLD 
a) This 9-month-old bov (case 12) was admitted because of febrile convulsion The child already 
had been under medical attendance because of supposed cerebral palsy At physical examination 
a discrete spastic tetraplegia was found The ASA activity in the leucocytes was very low and was 
considered to be consistent with MLD since both parents had ASA-activmes clearly in the hete­
rozygote range Metachromatic granules were found in the urine The CSF-protein level and the 
nerve conduction velocities were normal Since no clear evidence of a diffuse, progressive neuro­
logic disease was present, clinical MLD seemed unlikely Yet the possibility of an early stage of 
clinical MLD could not be excluded Therefore a sural nerve biopsy was performed No abnor­
malities were present in the biopsy specimen, von Hirsch-Pfeiffer reaction was negative These 
findings excluded clinical MLD 
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Fig. 1. Sulphatide-accumttlation 
in Schivami cells (S) and in 
macrophages (¡M) in the sural 
nene of case Ì2 (top photograph) 
compared to classical MLD 
(bottom photograph). 
Von Hirsch-Pfeiffer stain. 
Black dot\ represent mlphattde-
accumulations. 
b) This 48-year-old man (case 13) was presented with slowly progressive gait disturbances. Signs 
of pyramidal and peripheral nerve involvement and slight behavioural abnormalities were pre-
sent. The ASA-activitv in the leucocytes was ver\ low. but a reliable interpretation of this fin-
ding could not be made since his parents were not available for ASA-assay. The fibroblast-ASA-
activity was ven low as well (19 nmol/mg of protein/hr; mean control value 306 nmol/mg of 
protein/hr; range 123-490; η =30). A slight reduction of nerve conduction velocities was found. 
The CSF-protein level was normal. Adult MLD was diagnosed and sural nerve biopsy was perfor­
med. Surprisingly, the nerve contained only ven little metachromatic material (Fig. 1). which 
ultrastructurally did not resemble the material commonly found in MLD. In addition, priman· 
axonal instead of primary demyelinating neuropathy was present. These morphological data 
excluded clinical MLD. correcting a false positive diagnosis. Further family investigations provi­
ded a satisfying explanation for the clinical, electroneurographic and morphologic findings: 
HMSN type V (hereditary motor and sensory neuropathy with spasticity; Dyck 1975). 
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c) This 52 vcar old man (case 21) -with chronic psvchiatnc disturbances of supposedly organic 
cerebral origin was admitted to the hospital because of atypical seizures At physical examination 
choreatic dyskinesia left sided pyramidal signs and severe hypotonia were found The ASA acti 
vity in leucocytes and fibroblasts was low although slightly above the level v.c were used to find 
in MLD howeyer since information about the ASA acmity of his parenrs could not be obtai 
ned reliable interpretation of his ASA activity was impossible Nerve conduction velocities were 
markedly reduced CSF prorein level was normal Because of the combination of psychiatric dis 
turbances slow nerve conduction velocities and low ASA activity adult MLD seemed likely and 
sural nerve biopsy was performed in order ro confirm this diagnosis However in the biopsy 
specimen only insignificant amounts of metachromatic material were present in a few Schwann 
cells Ultrastructurally no material suggestive of sulphatides could be demonstrated In addition 
a rather active primary axonal neuropathy was found These morphological data excluded clini 
cal MLD correcting a false positive diagnosis 
d) This 15 year old boy (cast 22) was suffering from gair disturbances which were progressive 
since he was 12 years old At physical examination peripheral neuropath) pes cavus and signs of 
minimal brain dysfunction were present Electroncurography was consistent with demyelinating 
neuropathy His leucocyte ASA activity was considerably above the level we were used to find in 
MLD but it was very low compared wirh rhe ASA activity of his parents (6S and 5} nmol/mg 
of protein/hr) raising the possibility of homozygote MLD On clinical grounds however Char 
cot Mane 1 ooth disease (sporadic case) seemed most likely and sural nerve biopsy was performed 
ro support this diagnosis In the biopsy specimen ι chronic segmental dcmyelinating neuropathy 
with onion bulb formation w is found No material suggesnve of sulphandes could be demon 
stratcd These morphological data excluded clinical MID and supported the diagnosis of hypei 
trophic Charcot Mane Tooth disease (HMSN type I Dyck 1975) 
DISCUSSION 
Since the first diagnostic sensory nerve biopsy in MLD (Thieffry and Lyon 1959) 
numerous reports have confirmed the reliability of this procedure in the diagno­
sis of clinical MLD 
The characteristic morphological features in peripheral nerves are massive 
lysosomal accumulation of sulphatides in Schwann cells and in macrophages, 
and signs of a dcmyelinating and remyelinating neuropathy Although varying 
amounts of metachromatic material also can be found in the sural nerve of 
patients not having MLD or even control persons, massive accumulation in 
macrophages is only seen in MLD (Olsson and Sourander 1969) In more than 
600 sural nerve biopsies examined in our department, only 4 nerves of patients 
without clinical MLD contained metachromatic material, although in negligible 
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amounts compared to MLD. In the majority of MLD-patients demyelination of 
peripheral nerves is reflected in a marked reduction of nerve conduction veloci-
ties. Some MLD-patients, however, have normal conduction velocities (Fuller-
ton 1971, Hackett and Bray 1971, Percy et al. 1977). 
Since the introduction of the ASA-assay, a reliable basis for the diagnosis of 
clinical MLD commonly is found in the combination of clinical signs compati-
ble with MLD, low leucocyte-ASA-activity, marked reduction of nerve conduc-
tion velocities and elevated CSF-protein level. For an adequate interpretation of 
low ASA-activity in a person, information about the ASA-activities in the 
parents is essential. If both parents have ASA-activities clearly in the range of 
heterozygotes, low ASA-activity in their child is consistent with MLD (Dubois 
et al. 1975, 1977). In such a situation (as in our MLD-patients no. 1, 2, 4 and 5) 
confirmatory investigations like sural nerve biopsy might be superfluous, unless 
there is clinical doubt about the diagnosis (as in our patient no. 12, whose sural 
nerve biopsy excluded clinical MLD). However, if low ASA-activity is present in 
one of the parents, low ASA-activity in the child does not prove MLD. Adequa-
te interpretation of low ASA-activity is impossible in such a situation, which 
occurred in 4 of our 9 MLD-patients (no. 6, 9, 17 and 20, their 'low enzyme 
activity heterozygote' parents being no. 10, 11, 15 and 19). In another MLD-
patient (no. 3) and in two adult patients with low ASA-activities (no. 13 and 
21), reliable interpretation of low ASA-activity was impossible since information 
about the enzyme activities of their parents could not be obtained (these parents 
were dead). Misleadingly high ASA-activities have been found in MLD-patients 
(Turpin et al. 1974, Kihara 1976, Aleck et al. 1977, Bosch and Hart 1978). In 
our material this only occurred in MLD-patients with one low enzyme activity 
parent. In one case (no. 20) the ASA-activity was even so high that homozygote 
MLD at first was considered excluded. In another patient (no. 17), unusually 
high ASA-activity did cast some doubt on the diagnosis. 
In these cases, in which adequate interpretation of the ASA-activity is impos-
sible, additional investigations are desirable, and in some cases even essential in 
order to avoid diagnostic failures. These investigations commonly aim at the 
demonstration of sulphatide-accumulation in the sural nerve, which is common-
ly used, or skin (Dolman et al. 1975, Martin et al. 1978) or at the demonstration 
of above-normal excretion of sulphatides in the urine. Several other elaborate 
assays (review by Dulaney and Moser 1978) have been developed, but they will 
not be discussed here since they are only performed in very few laboratories. 
In our patients with low ASA-activity we have used sural nerve biopsy when 
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additional diagnostic information was required. This additional information 
appeared to be important for two reasons; 
1. To avoid false positive diagnosis of clinical MLD when low ASA-activity 
cannot be used as evidence of the disease, either because one of the parents 
has low ASA-activity (as in our MLD-patients no. 6 and 9) or because infor-
mation about the ASA-activities of the parents cannot be obtained (as in 
our patients no. 3 and 13). Of course, even in this situation it is generally 
right to diagnose MLD when clinical and electroneurographic signs compa-
tible with MLD are present. This was the case in our 3 MLD-patients no. 3, 
6 and 9, in all of whom sural nerve biopsy proved the diagnosis. However, 
the hazard of this assumption is demonstrated by our patient no. 13, who 
was diagnosed to have clinical MLD, based on clinical signs compatible 
with MLD, low ASA-activity and a reduction of nerve conduction veloci-
ties. Surprisingly, his sural nerve contained only very little metachromatic 
material, which ultrastructurally did not resemble the material commonly 
found in MLD. In addition, primary axonal instead of primary demyelina-
ting neuropathy was present. These morphological data excluded MLD, cor-
recting a false positive diagnosis. Further family investigation established 
the correct diagnosis: HMSN type V. This case clearly demonstrates that 
additional investigations are necessary when adequate interpretation of low 
ASA-activity is impossible in patients with clinical and electroneurographic 
signs compatible with MLD. 
2. To avoid diagnostic failures in patients with clinical and electroneurogra-
phic signs compatible with MLD, but with ASA-activity slightly above the 
level one is used to find in MLD. This occurred in our MLD-patients no. 17 
and 20, and in patient no. 21 without MLD. In all these cases adequate 
interpretation of the ASA-activity was impossible, either because one of the 
parents had low ASA-activity (cases 17 and 20) or because information 
about the ASA-activities of the parents could not be obtained (case 21). The 
unusually high ASA-activity in both MLD-patients did cast some doubt on 
the diagnosis in no. 17 and even forced us to reject the diagnosis of MLD in 
no. 20. Surprisingly, sural nerve biopsy established MLD in no. 20, correc-
ting a false negative diagnosis. The expected cerebral deterioration develo-
ped in the following years. In no. 17, sural nerve biopsy confirmed MLD. In 
patient no. 21, the marked reduction of nerve conduction velocities particu-
larly was considered to favour the diagnosis of clinical MLD. However, sural 
nerve biopsy excluded the diagnosis, since only insignificant amounts of 
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metachromatic material were present. In addition, primary axonal instead of 
primary demyelinating neuropathy was observed. 
These cases demonstrate that additional investigations should be performed 
when unusually high ASA-activity is found in patients with clinical and 
electroneurographic signs compatible with MLD. 
In preclinical MLD the diagnostic value of sural nerve biopsy cannot yet be 
established, since only few observations have been reported. Positive diagnostic 
information has been obtained by Milunsky et al. (1970) and Argyrakis et al. 
(1977). We did not perform sural nerve biopsy in any of the asymptomatic pos-
sible MLD-patients (no. 7, 8, 16 and 18), in all of whom ASA-assay could not be 
used to diagnose MLD, since one of the parents had low ASA-activity. 
Some of the more elaborate confirmatory assays (review by Dulaney and 
Moser 1978) seem to be particularly promising for the discrimination between 
the MLD-homo7ygote and the 'low enzyme activity heterozygote' in preclinical 
MLD-diagnosis, but their use is still limited. The value of electroneurography in 
the diagnosis of preclinical MLD has not been established. Of course, the combi-
nation of low ASA-activity and slow nerve conduction velocities is likely to be 
consistent with MLD (as in the case of Pilz and Hopf 1972), but this is not 
necessarily so (as shown by our patient no. 21). The measurement of sural nerve 
action potential has been considered useful to detect subclinical abnormalities in 
asymptomatic relatives of MLD-patients (Clark et al. 1979). 
To conclude, this paper demonstrates that additional information is essential 
when adequate interpretation of leucocyte-ASA-activity is impossible in patients 
with clinical and electroneurographic signs compatible with MLD. Furthermore, 
our observations demonstrate that sural nerve biopsy can be used to obtain this 
additional information. 
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ABSTRACT 
A 17-month-old boy with infantile globoid cell leukodystrophy is presented 
The diagnosis was made by enzymatic assay Atypical features of his disease in-
cluded a delayed onset at 12 months and a slow course At the time of diag-
nostic evaluation, 5 months after onset, the usual features of opisthotonos 
posture, slowing of nerve conduction and marked elevation of cerebrospinal 
fluid protein were still absent Sural nerve biopsy showed no significant demyeli-
nation and only inconspicuous deposition of the characteristic storage products 
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INTRODUCTION 
The usual criteria in making a tentative clinical diagnosis of infantile globoid 
cell leukodystroph\ (GLD) are a typical clinical history, a retarded infant in a 
characteristic opisthotonos posture, markedly raised cerebrospinal fluid (CSF) 
protein with normal cell count, and marked slowing of nerve conduction due to 
segmental demyelination 
In the current paper we present a boy with infantile GLD whose disease was 
difficult to recognize clinically since the usual citena were lacking 
CASE REPORT 
This bo\ was the first child of non consanguineous parents At the age of one he was able to 
walk with support and could speak a few words Some weeks after his first birthdav, these abili 
ties began to disappear and progressive deterioration of his mental and motor performance beca­
me manifest Imtabilit\ and episodes of intense e n m g had not been noted b\ the parents to be a 
prominent feature of their son's disease Observation in his local hospital at the age of 14 
months did not lead to a definite diagnosis During his sta\ there, he was noted to have periods 
of unexplained lowgrade fever 
At I 7 months the child was referred to our clinic O n admission the bo\ was profoundh 
hvpotomc, lying раьы еН in a frog like posture without an\ attempts to roll over or sit M\oclo 
nie jerks occurred spontaneoush all over his bod\ He was ver) quiet most of the time except on 
being handled, to which he easih reacted b\ crving and, octasionalh, bv tonic spasms He did 
not grasp at a to\ held in front of him, and he followed the visual test objects onh for a few 
seconds His social response was limited to looking and smiling He did not speak, and did not 
seem to comprehend am simple language It was obvious, however that he still recognued his 
parents Testing of muscle tone revealed that the limbs became increasinglv stiff during passive 
movement The thumbs were held adducted The proximal tendon jerks were hvperactive, but 
the distal reflexes were low Plantar responses were equivocal Distal muscles seemed atrophic 
hxamination of the tundí revealed no optic atropln 
The cerebrospinal fluid contained 65 mg percent of protein, with normal cell count Conduc 
tion velocities in the tibial posterior nerve (motor) and sural nerve were normal Computerized 
tomographic brain scan (using a second generation scanner) was normal including a normal 
white matter appearance The diagnosis of GLD was made b\ demonstrating a profound decrea-
se of galactos\l ceramide-beta galactosidase activit\ in cultured fibroblasts (residual activit\ 0 22 
nmol /hr /mg of protein, normal range, η = 3 0 15 5 0 nmol/hr/mg of protein) The results of 
neuromuscular biopsv are presented separatch (vide infra) 
The bo\ was discharged at 18 months At 19 months he was readmitted to the local hospital 
During his 5 months sta\ there, his condition deteriorated and he gradualh developed a perma 
nent opisthotonos posture Unfortunatch, the parents refused an\ 'unnecessary control investi­
gations (including nerve conduction stud\ ) to be carried out on their child 
At 28 months the bo\ died There was no autopsv 
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SURAL NERVE BIOPSY STUDY 
The patient was biopsied at the age of 17 months. The methods have been des­
cribed (Joosten et al. 1974). 
Light and electron microscopic examination of nerve sections. 
There was a normal density and diameter distribution of myelinated fibers. No 
active degeneration of myelin was seen. The axons had a normal appearance. 
Totally demyelinated axons did not occur. Only a few fibers had a relatively thin 
myelin sheath, occasionally surrounded by a small onion-bulb structure. In the 
acid phosphatase stain, perinuclear activity was observed in only some of the 
Schwann cells. Along the myelin sheaths, however, many acid phosphatase-active 
spots were visible with a clear maximum in the paranodal region. A few big acid 
phosphatase-active macrophages were seen lying around endoneurial vessels. 
Only very few Schwann cells and macrophages contained vacuoles filled with 
characteristic deposits (Fig. lA, B). 
Fig. 1 A. Electron micrograph of sural nerve. The remyelinated fiber in the middle is surrounded by a 
small onion-bulb structure. The two macrophagal processes near this fiber contain lysosomal vacuoles filled 
with storage material: in the one on the left needle-shaped structures are particularly prominent, in the 
lower one the curved tubular appearance dominates. Bar = 2 μηι 
Fig. I B . Detail of A showing the lower macrophagal process with its vacuole filled with curved tubular-
shaped deposits. sometimes with paired-twisted appearance. Bar = 0.56 ßm. 
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Table Results of teased fiber stuch 
Present case 
Typical infantile case 1 
T\pical infantile case 2 
Typical infantile case 3 
Controls'1 
Age 
(months) 
Π 
5 
7 
9 
Number 
teased 
fibers 
50 
105 
39 
52 
of 
A 
82 
41 
28 
35 
99,7 
D i s m b u n o n of types 
of fibers (%)·' 
С D 
8 0 
16 29 
28 34 
33 17 
0 3 0 
F. 
0 
0 
0 
0 
0 
F 
10 
14 
10 
15 
0 
Abnormal 
(%) 
18 
59 
72 
65 
0 3 
* Capitali refer to the condition of the teased fiber A = normal appearance. С = widening of nodal gap, 
D = segmental dctmclinacion.E =axonal degeneration with linear rows, of rmelin balls,F = segmental 
or paranodal rermclinarion 
Control values obtained h\ grading a total of 248 teased fibers from 10 age-matched controls with no 
signs of a neuromuscular disorder 
•Teased fiber study 
The results are summarized in the Table. For the sake of contrast, the results of 
teased fiber study in 3 fully developed typical infantile cases are also presented in 
the table. The most striking result in the present case is the absence of segmen­
tal demyelination (condition D). The abnormalities in this patient were restric­
ted to widening of nodal gaps (condition C) in 8% and paranodal remyelination 
(condition F) in 10% of the fibers. In the 3 typical cases, a large number of the 
fibers is abnormal, with a particularly frequent occurrence of conditions С and 
D. None of the fibers showed axonal degeneration with linear rows of myelin 
balls (condition E). 
SOLEUS MUSCLE BIOPSY STUDY 
No neurogenic atrophy was observed in the muscle biopsy specimen. The intra­
muscular nerve bundles had a normal appearance, except for their increased acti­
vity in the acid phosphatase stain. 
DISCUSSION 
Recognition of GLD in our patient was difficult since the usual features of the 
disease were lacking. 
59 
In typical infantile cases the disease starts in the first half year of life, and 
irritability is nearly always the initial symptom (Hagberg et al. 1969). The disea-
se in our patient did not start until he was one year old, and irritability was not 
the initial manifestation. In typical infantile cases the course is rapidly progressi-
ve and, therefore, the characteristic features of opisthotonos posture, slowing of 
nerve conduction and marked elevation of CSF protein usually have developed 
already at the time when the definite diagnostic investigations are being perfor-
med. In our patient progression was much slower and, therefore, he was still at 
an early clinical stage of his disease at the time of diagnostic evaluation (5 
months after onset), not yet having developed the features which would have 
made his disease much easier to recognize. He did not exihibit a permanent 
opisthotonos posture, did not have slowed nerve conduction and did have only 
moderately increased CSF protein. 
With regard to involvement of the peripheral nervous system (PNS), nearly 
all morphologic studies have shown that segmental demyelination of the peri-
pheral nerves is a constant feature in infantile GLD (Suzuki and Suzuki 1978). 
This is also our own experience (results of teased fiber study in 3 typical cases' 
see Table). A recent electrodiagnostic observation (Lieberman et al. 1979) sho-
wed that the neuropathy may be demonstrable even before any other symptom 
of the disease has developed. In our patient, involvement of the PNS was sug-
gested by the low distal tendon reflexes. The finding of normal nerve conduc-
tion, however, suggested that any significant segmental demyelination of the 
peripheral nerves had not yet developed. This was confirmed by sural nerve biop-
sy, showing that the process of demyelination and remyelination, though it had 
started to develop in the paranodal region, did not yet affect whole segments. 
With regard to CSF protein level, the value in our patient (only 65 mg percent) 
was much lower than the values plainly above 100 mg percent usually seen in 
the fully developed typical infantile cases (Hagberg et al. 1969). Unfortunately, 
since no control investigations were permitted, we are not sure whether slowing 
of nerve conduction or further increase of CSF protein developed in our patient 
during the later stages of his disease. 
We do not believe that our patient represents a case of late onset GLD. The 
reported late onset cases developed the first symptoms after the age of two, and 
their initial clinical picture was dominated by failing vision due to cortical 
blindness with optic atrophy, difficulties of walking and spasticity with pyrami-
dal signs (Crome et al. 1973). The onset in our patient was much earlier, and 
still in infancy. His initial symptoms did not include failing vision, nor distur-
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bances of gait. In addition, hypotonia rather than spasticity was dominant in the 
early phase of his disease. 
A final point raised by the atypical presentation in our patient is the old ques­
tion (Anzil et al. 1972) whether infantile GLD may prove to be a group of 
biochemically distinct storage disorders rather than a biochemically homogenous 
condition. It seems questionable, indeed, whether the typical patients and clini­
cally so different cases like our patient or the atypical ones described by Black­
wood and Cumings (1954), Hogan et al (1969) or Dunn et al. (1976), all mere­
ly represent the variable clinical expression of one homogenous condition. 
Appropriate studies which settle this problem are not yet available. 
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Ill 1.3 
THE NEUROPATHY OF COCKAYNE 
SYNDROME 
A. Vos, A. Gabreëls-Festen, E. Joosten, F. Gabreëls, 
W. Renier and R. Mullaart 
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ABSTRACT 
We studied three unrelated infants and three adolescent siblings with Cockayne 
syndrome. The infants showed severe psychomotor retardation. Neurologic 
manifestations in the siblings were less severe and only slowly progressive. All 
patients had slowed peripheral nerve conduction. Nerve biopsies demonstrated a 
process of segmental demyelination and remyelination in each case. In the infan-
tile cases this process was severe and rapidly progressive; in the juvenile cases it 
was mild and chronic. Distinctive membrane-bound polymorphous inclusions 
were found in occasional Schwann cells. 
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INTRODUCTION 
Involvement of the peripheral nervous system (PNS) in Cockayne syndrome 
(CS) was first reported by Moosa and Dubowitz (11). Their patient had sluggish 
tendon reflexes, slowed nerve conduction and segmental demyelination on sural 
nerve biopsy. Nerve conduction studies of other cases (1-7, 9, 12, 16) revealed 
that PNS involvement, with few exceptions (6, 8, 17), is common in CS. The 
histopathology of the PNS lesion, however, is still open for discussion because 
segmental demylination, as in the case of Moosa and Dubowitz (11), was repor­
ted in only three other cases (6, 12, 16); nerve biopsies in five other patients 
with slowed nerve conduction revealed only nonspecific alterations (9) or none 
at all. (4, 7, 13). 
MATERIAL AND METHODS 
The entena for diagnosis in these patients are presented in Table 1 ; all or nearly all of the 
principal features (14) were present The patients had healthv and unrelated parents Birth 
weights were normal or low normal. The three infants (cases 1-3) developed slowly from the 
first months of life and, at the time of study, they showed severe psychomotor retardation The 
three adolescent patients (cases 4-6) were siblings with a mild illness; neurologic manifestations 
appeared late (approximateh at age J years) and progressed slowly Late onset and mild course 
probably explain why the characteristic feature of microcephaly was not seen In the youngest 
sibling (case 4) neurologic disability was still slight. A detailed report of these siblings has been 
presented elsewhere (14) 
Tabic 1. Diagnostic criteria 
Patient no 
Age(\r) 
Dwarfism 
Mental retardation 
Senile appearance 
MicrocephaK 
Central motor disturbances 
Photosensitive dermatitis 
Retina pigmentation 
Intracerebral calcifications 
1 
2 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
2 
2 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
3 
3 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
4 
Π 
+ 
+ 
+ 
-
+ 
+ 
-
+ 
•5 
16 
+ 
+ 
+ 
-
+ 
+ 
-
+ 
6 
19 
+ 
+ 
+ 
-
+ 
+ 
-
+ 
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Velocity 
m/sec 
+ 2 SD 
mean control 
-2SD 
ι • ' • • ι ι— 
0 5 10 15 20 
·- Age (years) 
Fig. 1 Conduction velocity in motor fibers of left median nerve in forearm 
Reduced tendon jerks and distal amyotrophy were present in the eldest sibling In the other 
patients there were no clinical signs of neuropathy Nerve conduction, however, was slowed in 
all six cases (for motor fibers in the median nerve this is shown in Fig 1, slowing in other 
motor nerves was in the same range) Digital nerve action potentials were low or unobtainable 
Electromyography (EMG) revealed a chronic neurogenic lesion in the eldest sibling, in the other 
patients EMG was normal 
Sural nerve biopsies were performed at the midcalf level In case }, only the obturator nerve 
(biopsied at adductor tenotomy operation) was examined Cryostat sections of the nerves were 
stained with hematoxylin-eosin, toluidine blue, Sudan Black B, periodic acid Schiff and cresyl 
violet (von Hirsch Pfeiffer), and were also used for demonstration of vanous enzyme activities, 
including acid phosphatase Part of the specimen was fixed in 2% glutaraldehvde buffered with 
sodium cacodylate pH 7 4, postfixed in 2% OsO, in Palade buffer pH 7 4 and after dehydration 
in alcohol embedded in Epon 812 Semi thin sections of this block, stained with uranvl acetate 
and lead citrate, were examined under the light microscope Ultra thin sections of the same 
block were similarly stained and examined in a Philips EM 300 From each sural nerve approxi­
mately 40 single myelinated fibers, each with a minimum of 4 internodes, were teased from one 
fascicle fixed in 2% calcium chloride and 4% formaldehyde and postfixed in 1% OsO, in 0 1 M 
phosphate buffer pH 7 4 
RESULTS 
In the three infants (cases 1-3) cross-sections of the nerves revealed several 
demyelmated axons and many recently remyelmated axons, but virtually no 
onion bulbs (Fig 2) There was no evidence of axonal degeneration Teased fiber 
study (cases 1 and 2) impressively confirmed the severity of the myelinopathy 
eo, 
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Fig. 2. Cross-section of wral nerve (case 2). Several axons are completely demyelinated (closed arrows) or 
recently remyelinated (open arrows). No significant formation of onion bulb structures. 
Table 2. Summary of neuropathic findings 
Case 
1 
2 
}b 
\ 
5 
6 
Age 
(yrs) 
2 
2 
3 
13 
16 
19 
Cross-sections 
Dcmve-
lination 
+ 
+ 
+ 
-
-
+ 
Recent 
remye-
lination 
+ 
+ 
+ 
+ 
+ 
+ 
Onion 
bulbs 
+ 
± 
± 
-
+ 
+ + 
Teased fiber prep; 
Fibers with 
demvelinated 
segments (%)a 
9 
24 
3 
2 
6 
¡rations 
Fibers with 
remyelinated 
segments {%У 
24 
31 
17 
20 
24 
a
 Control values, fibers with dcrmclinatcd segments: O'/c. fibers with rcrmelinated segments: <49f 
° no teased fibers obtained 
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Fig. 3. Cross-section of sural nerve (case в). Man) myelinated fibers are surrounded by one or more 
layers of Schwann cell processes (onion bulbs). Several fibers show evidence of recent remyelination. Mye­
linated fiber density /i clearl) decreased. 
(Table 2). In the youngest sibling (case 4), myelinated fibers in cross-sections 
showed no abnormalities except occasional evidence of recent remyelination. 
Segmental de- and remyelination was convincingly demonstrated in this nerve, 
however, on teased fiber study. In the eldest sibling (case 6) cross-sections revea­
led only a few demyelinated axons, many recently remyelinated axons and a lar­
ge number of onion bulbs (Fig. 3). Small clusters were observed sporadically. 
Teased fibers also provided an impressive view of the lesion. In the remaining 
sibling (case 5) mild segmental de- and remyelination with some formation of 
onion bulbs was found. Abnormalities in this nerve were less pronounced than 
in the eldest sibling. 
In a small number of Schwann cells, associated with myelinated as well as 
unmyelinated axons, a large amount of membrane-bound polymorphous inclu-
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Fig. 4. Membrame-bound inclusions with small vacuoles closely arranged together in an electron-dense 
homogenous ground substance are visible in a Schwann cell. This Schwann cell is part of an unmyelinated 
fiber containing a number of unmyelinated axons (A). 
sion material was evident (Fig. 4). These large inclusions did not contain lamel-
lar material derived from myelin, nor were they comparable with later stages of 
myelin degeneration. They displayed an electron-dense ground substance in 
which were embedded vacuoles with a granular or membraneous content. They 
were seen in the infantile and juvenile cases. 
DISCUSSION 
Our study provides further histophathologic data of the PNS lesion in CS. On 
physical examination, PNS involvement was inapparent in all but case 6. Slow 
nerve conduction, however, was constant (Fig. 1). The biopsies revealed that the 
neuropathy is characterized by a process of segmental demyelination and remye-
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lination. In the severely retarded infants (cases 1-3) this process was severe and 
rapidly progressive, with widespread demyelinated and recently remyelinated seg-
ments but virtually no onion bulbs. A less severe and much slower process of dc-
and remyelination was observed in the slowly deteriorating siblings (cases 4-6), 
where PNS abnormalities gradually developed from a very mild lesion in the 
early years of the disease (case 4) to a moderately severe neuropathy with promi-
nent onion bulbs seen later (case 6). In most of our patients de- and remyelina-
tion was conspicuous in teased fiber preparations; the lesion in the very mildly 
disabled youngest sibling (case 4) could have been overlooked if only cross-sec-
tions of the nerve had been studied. Therefore the lesion may have been missed 
in the negative biopsy studies of patients with slow nerve conduction (4, 7, 9, 
13) but no teased fiber studies. 
Out data leave little doubt that, in CS, the demyelination, which is one of the 
hallmarks of CNS pathology (15), usually involves the PNS as well. We con-
firm previous suggestions (11) that CS presents features of a generalized progres-
sive leukodystrophy. A distinctive additional feature in our cases was the mem-
brane-bound polymorphous inclusions in occasional Schwann cells (Fig. 4). 
They could be evidence of a lysosomal storage disease, but other interpretations 
are possible. They occurred both in myelinated and unmyelinated fibers and the 
ultrastructural characteristics do not suggest an origin in degenerated myelin. 
Similar material has probably been seen in another infantile case, described as 
coarsely granular electrodense material (10). 
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Ill 2 
SURAL NERVE BIOPSY IN THE DIAGNOSIS 
OF DIFFUSE 
CEREBRAL DEGENERATIVE DISORDERS 
OF ADULTS 
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ABSTRACT 
Sural nerve biopsies were studied in 10 adults with diffuse cerebral degenerative 
disorders. The findings consisted of segmental demyelination with specific depo-
sits in 2 patients with adult metachromatic leukodystrophy (MLD), axonal neu-
ropathy with massive accumulation of polyglucosan (Lafora) bodies in 2 patients 
with adult polyglucosan body disease (APBD), axonal de- and regeneration in 2 
patients with cerebrotendinous xanthomatosis (CTX) and mild axonal chronic 
axonal involvement in 3 unclassified cases. In one unclassified case the findings 
were entirely normal. 
On the basis of the observations in these cases, and on the basis of the data 
reported in the literature, the diagnostic value of sensory nerve biopsy in adults 
with diffuse cerebral degeneration is discussed. It is concluded that performance 
of the biopsy at present remains indicated only in patients with overt clinical 
neuropathy in whom all other investigations (including skin or conjunctival 
biopsy) have been unrewarding. 
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INTRODUCTION 
In the literature, most of the available nerve biopsy studies in diffuse cerebral 
degenerative disorders of adults appear devoted to the findings in adult meta­
chromatic leukodystrophy (Hirose and Bass 1972; Czmok et al. 1974; Joosten et 
al 1975; Guseo et al. 1975; Argyrakis et al. 1977; Goebel et al. 1977; Percy et al. 
1977, Thomas et al. 1977; Bosch and Hart 1978; Luyten et al. 1978; Martin 
1982). In other conditions, however, only few nerve biopsy studies have been 
presented, and no systematic information is available as to the contribution 
which biopsy can provide in the diagnosis of these disorders. 
In our present study we describe our experience with sural nerve biopsy in 10 
patients with diffuse cerebral degenerative disorders, and we discuss the indica­
tions for biopsy in such conditions in relation to the current diagnostic views. 
PATIENTS A N D METHODS 
Ten piticnts with progressive cerebral degeneration were studied (Table 1 ) 
The group consisti of two patients with idult met.ichromatic leukod\strophv (cases 1 and 2), 
two patients with adult pohglvcosan bod\ disease (APBD cases 3 and 4), two patients with 
Table 1. Clinical and nerve biops\ findings in 10 adults with diffuse cerebral degeneration 
Case 
1 
2 
3 
4 
5 
6 
Ί 
8 
9 
10 
Diagnosis 
Metachromatic Icukodvstropfn 
Metachromatic leukodvstroph\ 
Adult pohglucosan bod\ disease 
Adult poluglucosan bod\ disease 
Cerebrotendmous xanthomatosis 
Cerebrotendinous xanthomatosis 
Unclassified 
Unclassified 
Unclassified 
Unclassified 
Age 
30 
30 
60 
49 
36 
42 
46 
25 
39 
33 
Sensation 
η 
• 
• 
* 
η 
η 
η 
η 
η 
η 
M N C V ' 
15 
25 
35 
38 
43 
38 
41 
38 
50 
48 
SNAPS' 
_ 
2 
-
N R 
10 
6 
-
5 
-
-
b 
S D ' 
+ 
+ 
Sural 
iops\ 
SDR 
+ 
+ 
nerve 
findings 
1
 ADR' L" 
+ + 
+ + 
+ 
+ 
+ 
+ 
+ 
1
 Sensation n= normal, f impaired. 'MNCV motor nerve conduction velocin (peroneal ner\e) in m/s. mean 
control value 50 m/s, range 12-58. 'SIsAPs senson nerve action potentials (sural nerve) in microVolt. mean 
control value 9μν, range 3-20 μν, - not measured, NR no response obtainable, 'SD specific deposits, ^SDR 
segmental de and rermclmation. 'ADR axonal dc-and regeneration, "L Lafora bodies 
75 
cerebrotendinous xanthomatosis (CTX. cases 5 and 6) and four unclassified cases (no ^-10) In 
all cases, except the two with APBD, there was significant dementia In the two with APBD, 
diffuse and marked cerebral involvement was evident from LPEG (case 3) or CT scan (case Í) 
Sensation (if rehablv testable) was found impaired in cases 2-4, in the others, sensation was 
normal Motor nerve conduction was normal in 3 cases (no 'i, 9 and 10), shghtlv slowed in 5 
cases (no 3, 4.6i, 7 and 8) and severely slowed in the two with MLD (cases 1 and 2) Sural nerve 
action potentials were measured in 5 cases, and were found normal in three (no 5, 6 and 8) and 
abnormal in two (no 2 and 4). 
Sural nerve biopsy specimens in all cases were obtained from the midcalf level Obtained spe-
amens were processed according to the methods described in chapter II 
RESULTS 
A summary of the biopsy results is included in Table 1. 
In the two patients with MLD (1 and 2) the findings consisted of relatively 
mild segmental de- and rcmyelination, associated with accumulation of sulphati-
des (von Hirsch-Pfeiffer stain). 
In the two patients with APBD (3 and 4) chronic axonal neuropathy with 
reduction of large myelinated fibers was found, in addition to massive accumula-
tion of Lafora bodies. 
In the two patients with CTX (5 and 6) the biopsy findings consisted of mild 
chronic axonal de- and regeneration, without any additional remarkable features. 
In the four unclassified patients (7-10) the biopsy showed mild chronic axo-
nal de- and regeneration without significant fiber decrease in 3 cases (7-9), and 
normal findings in one (no. 10). 
DISCUSSION 
Our study illustrates that performance of sensory nerve biopsy can provide a 
positive diagnostic contribution in some adults with diffuse cerebral degenera-
tion. The major applications in our scries were found in two patients with adult 
metachromatic leukodystrophy (confirmation of the enzymatic diagnosis: cases 
1 and 2) and in two patients with adult polyglucosan body disease (establish-
ment of the diagnosis: cases 3 and 4). The latter condition was recently recogni-
zed as a distinct disease entity which in life can be diagnosed by sural nerve 
biopsy (Robitaille et al. 1980). With the observations in our two cases we have 
confirmed the usefulness of nerve biopsy in this condition, and we have demon-
strated additionally that occurrence of polyglucosan (Lafora) bodies in this dis-
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Table 2. Biop!>\ findings in diffuse cerebral degeneration of adults (literature data) 
Diagnosis 
Involvement 
at nerve biops\ 
Current diagnostic 
approach 
Metathrorrutic leukod\ stroph\ 
Adult pohglucosan bod\ disease 
Cerebrotendinous xanthomatosis 
Adrenoleukom\ c!oneurop,ith\ 
Late onset globoid tell leukodvstroph\ 
Ceroidlipofuscinosis 
+ (Hirose and Bass 1972) enzyme assa\ 
+ (Robitaille et al 1980) skin biopsy' (Vos et al 198Í) 
+ (Ohnishi et al 1979) biochemical assay 
(O'Neill et al 1981) 
(Crome et al 1973) 
(Dom et al 1979) 
biochemical assav 
епл me assav 
skin biopsy (Ceuterick 
and Martin 1984) 
order can also be demonstrated in skin (Vos et al. 1983: see chapter III 2.1). In 
our two patients with cerebrotendinous xanthomatosis (CTX: cases 5 and 6) the 
biopsy finding of axonal de- and regeneration did not provide a positive contri­
bution to the diagnosis itself, but nevertheless appeared valuable by delivering 
arguments for neuroaxonal factors in the pathogenesis of this disorder (Pop et 
al. 1984: see chapter III 2.2). 
The liminations of sensory nerve biopsy in adults with diffuse cerebral dege­
nerative disorders are illustrated by our four unclassified cases (no. 6-10) in 
which the procedure, rather than providing any contribution to the diagnosis, 
merely revealed evidence of mild and nonspecific axonal involvement (no. 6-9) 
and, in one case (no. 10), even no evidence of involvement at all. 
In the literature (Tabic 2), pathological involvement of peripheral nerves in 
diffuse cerebral degeneration of adults has been described in MLD (Hirose and 
Bass 1972; for other references: see introduction), in APBD (Robitaille et al. 
1980), in adrcnoleukomyeloneuropathy (O'Neill et al. 1981) and in CTX 
(Ohnishi et al. 1979). Absence of peripheral nerve involvement has been repor­
ted in late onset globoid cell leukodystrophy (Crome et al. 1973) and in ceroid-
lipofuscinosis or Kufs disease (Dom et al. 1979). As can be seen in the last 
column of the table, less invasive procedures are currently being used for diagno­
sis in all the listed conditions, with the exception of APBD. In the latter dis­
order, sural nerve biopsy in our view still remains the diagnostic procedure of 
choice, even though our observation of polyglucosan bodies in dermal nerve 
bundles in this condition (see chapter III 2.1) suggests that skin biopsy may also 
be useful. Confirmation of this finding is needed in additional cases, however, 
before definite conclusions can be drawn. 
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Curiously, no peripheral nerve biopsy studies have been reported in such well-
known conditions as Pick's disease and Alzheimer's disease. Usefulness of the 
procedure in these conditions therefore cannot be considered excluded, though 
it seems unlikely that the biopsy will appear of much diagnostic help in these 
disorders as the peripheral nervous system in these conditions, at least clinically, 
is uninvolved. 
On basis of all previous data we have to conclude that performance of sural 
nerve biopsy deserves no routine place in the evaluation of diffuse cerebral dege­
nerative disorders of adults, since the diagnostic information obtained by the 
procedure can usually be obtained also in a less invasive way. In view of this, 
performance of the procedure at least should be limited to patients in whom 
all other investigations (including skin or conjunctival biopsy) have been unre­
warding. In addition, since little contribution is to be expected from biopsies in 
patients whose peripheral nerves appear clinically uninvolved (see our experience 
in children with such disorders: chapter III 1), we suggest that the procedure be 
further limited to patients with overt clinical neuropathy. 
If these two limitations are accepted, unnecessary biopsies in diffuse cerebral 
degenerative disorders of adults will be largely avoided. 
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Ill 2.1 
ADULT POLYGLUCOSAN BODY DISEASE: 
CLINICAL AND NERVE BIOPSY 
FINDINGS IN TWO CASES 
A.J. M. Vos, E. M. G. Joosten and A. A. W. M. Gabrecls-Fesren 
Annals of Neurology 1983; 13:440-444 
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ABSTRACT 
Two women suffered from a similar, slowly progressive illness characterized by 
upper and lower motor neuron involvement, sensory disturbances, and neuroge-
nic bladder. Radiographic examinations showed cerebral atrophy and, in one, 
changes on computerized tomography suggesting leukodystrophy. Sural nerve 
biopsies revealed axonal neuropathy associated with a large number of polyglu-
cosan bodies accumulating predominantly but not exclusively in myelinated 
axons. 
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INTRODUCTION 
Recently, adult polyglucosan body disease was recognized as a distinct climco-
pathological entity (2) characterized by progressive upper and lower motor neu­
ron involvement, neurogenic bladder, marked sensory loss predominantly in the 
legs, and, in some cases, dementia The pathological hallmark of the condition is 
the finding of a large number of polyglucosan bodies (a generic name referring 
to Lafora bodies, corpora amylacea, and all other similar structures) in central 
and peripheral neuronal processes and in astrocytes Diagnosis in life was sug­
gested to be possible by sural nerve biopsy 
Six cases have been described until now (1-3) This paper presents two addi­
tional cases with new aspects of peripheral nerve abnormality 
CASE REPORTS 
Patient I 
A woman 46 )ears of age complained of weakness in the legs Neurological examination revea­
led generalized hyperactive deep tendon reflexes bilateral Babinski signs, and slightly decreased 
perception of pain and vibratory sensations below the knee level There was no family history of 
neurological disease Cerebrospinal fluid (C SF) protein content was elevated to 65 mg/dl with 
an increase of gamma globulin to 25 ЬЧЬ but no ohgoclonal bands cell count was normal bree 
gastric acid was present, and serum vitamin B, value was normal She received immunosuppres 
sive therapy for three weeks with no benefit Reexamination three years later revealed similar 
findings except for almost complete loss of ankle reflexes This time CSF was normal including 
a normal gamma globulin content Glucose tolerance test (GFT) and serum triiodothyronine 
and thyroxine were normal Motor nerve conduction in the legs was reduced to approximately 
80% of mean control value in the arms it was normal An electromyogram showed no sponta­
neous activity at rest, on volitional activity there was reduced recruitment of longduration 
motor units in the tibial anterior and gastrocnemius muscles Biopsy of skin and peripheral 
nerve was performed In the period of this reexamination her right breast was amputated because 
of a small adenocarcinoma No metastases were detected At age 5} urge incontinence of urine 
and mild fecal incontinence developed 
By age 56, weakness of the legs had progressed to inability to climb stairs unassisted There 
were no signs of metastases bxcept for poor recent memory, her mental status was unremarka­
ble There was distal muscular atrophy of the legs with bilateral peroneal weakness, and impaired 
perception of pain and vibrations below knee level Sensation in the hands was normal The feet 
were hyperemic The deep tendon reflexes were hyperactive throughout except for reduced ankle 
reflexess Plantar responses were extensor Abdominal reflexes were elicitable Palmomental 
reflex was present bilaterally Anal reflexes were absent Cystography, cystoscopy, and cystometry 
revealed a chronic neurogenic bladder Motor nerve conduction was in the same range as seven 
years before, but recruitment of motor units in the lower legs was progressively reduced, associa 
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ted with an increase of unit duration and amplitude N o suial nerve action potential was discer­
nible Median nerve sensor\ action potential was normal Computerised tomographic (СГ) scan 
revealed marked cortical atroph\, particularh in the frontal area and a white matter appearance 
consistent with mild leukod\stroph\ There was no ventricular dilatation 
Patient 2 
A woman 57 \ears of age was admitted because of sudden falls in the \ear prior to admission 
SlowU progressive urge incontinence of uiinc and feces had started at the age of 'M N O similar 
disease had occurred in the famiK For several u a r s she had been under medical attention for 
coronarv insutficiencv. aortic stenosis, and Inpertension 
On neurological examination she was alert and oriented There was distal muscular atrophv of 
the legs with bilateral peroneal weakness Pain sensation was decreased in the lower legs and the 
perianal region Vibration sense was impaired at the ankle level Rectal sphincter tone was poor 
The knee |erks were brisk, but the ankle reflexes were reduced Plantar responses were e1 tensor 
The abdominal reflexes were present, deep tendon reflexes of the arms were reduced M\elogra-
phv was normal CSF protein level, Immunoelectrophoresis, and cell count were normal G T T 
and scrum tniodothvronine and thvroxine were normal (vstoscopv revealed a chronic neuro 
genie bladder Motor nerve conduction in the legs was slowed to approximateh 7 0 # of mean 
control value, in the arms it was normal Llectrom\ograph\ showed no spontaneous activin 
at rest, voluntan recruitment was markedlv reduced in the lower leg muscles, but normal in the 
quadriceps and arm muscles An electroencephalogram was normal Pneumoencephalography 
revealed moderate ventricular dilatation associated with marked cortical atrophv. particularh in 
the right frontal area Cerebral four-vessel angiography wasnormal Electrocardiography indicated 
coronarv insutticiencv and left ventricular hvpertrophv 
N o diagnosis was made During the ensuing vcars the patient became completely incontinent 
of urine while weakness in the legs progressed At age 60 biops\ investigation of muscle and 
nerve was performed She was still ambulant and mentally unrcmarkible when she suddenly died 
at age 63 Permission for autopsy was not obtained 
MATERIALS AND METHODS 
Cryostat sections of the sural n e n e (biopsied at midcalf level) were stained with hematoxylin 
and eosin (H&F), toluidinc blue Sudan III and IV, Sudan Black В and periodic acid Schiff 
(PAS) before and after exposure to α amylase for half an hour Paraffin sections were used for 
Bodian silver impregnation Single myelinated fibers (40 from Patient 1, 80 from Patient 2), 
each with a minimum of four internodes. were teased from one fascicle fixed in 27c calcium 
chloride and 1% formaldehyde and postfixed in \4 osmium tetroxide in 0 1 M phosphate buffer, 
pH 7 4 Material for electron microscopy was fixed in 2rA glutaraldehydc buffered with sodium 
cacodylate, pH ^ 4, postfixed in 27c osmium tetroxide in Palade buffer. pH n 4, and, after dehy­
dration in alcohol, embedded in Epon 812 Lltrathin sections were stained with uranvl acetate 
and lead citnte Sections of the soleus muscle (Patient 1) were studied with H&E. PAS. and 
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adenosine triphosphatase stain. Sections of the skin (Patient 2) were studied with H&E, PAS. 
toluidine blue, and plasmai. 
RESULTS 
Sural Nerve Biopsy 
PATIENT 1. A decreased density of myelinated fibers was noted with a marked 
loss of large-diameter fibers. Ovoids of axonal degeneration were seen occasio­
nally. Many regenerative clusters of myelinated axons were present. The histo-
chemical sections contained large numbers of round or oval structures up to 30 
μηι in size, distending the axons (Fig. 1). The myelin sheaths surrounding these 
structures were thinned. Occasionally, multiple swellings were seen in a single 
axon. They stained strongly positive with PAS before and after exposure to 
α-amylase for half an hour. Less well organized conglomerates of PAS-positive 
Fig. 1. (Patient I) Longitudinal section showing oval swellings of sural nerve axons. (Bodian silver: χ 
325/ 
X5 
Fig. 2. (Patient IJ Unmyelinated axon distended hy apolyglucosan body, (x 13.000J. 
material occurred around endoneurial blood vessels. Electron microscopy sho­
wed typical polyglucosan bodies in many myelinated axons, in ю т е unmyelina­
ted axons (Fig. 2), and occasionally in Schwann cells (Fig. 3). Irregularly shaped 
conglomerates of polyglucosans, apparently in the state of being digested by 
lysosomal activity, were seen in endoneurial perivascular macrophages. No amy­
loid was observed. In the teased myelinated fiber preparations nearly one-third of 
the fibers contained one or more swellings, occasionally in such a large number 
as to give the fiber a string-of-beads appearance (Fig. 4). Half of these fibers 
appeared normal otherwise; the other half either contained one or more demyeli-
nated internodes or showed progressive thinning of myelin or loss of osmiophi-
lia (or both) toward one side of the internodes. 
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Fig. 3. (Patient IJ Polyglucosan body (PBJ located inside a Schwann cell. Arrows point to basement 
membrane (x 4.700). 
Fig. 4. (Patient I) String-of-beads appearance of single teased myelinated fiber. (Osmium tetroxide; 
χ 100). 
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PATIENT 2. Density of myelinated fibers was normal, but there was a loss of 
large-diameter fibers. Axonal degeneration was observed occasionally. Some 
fibers were remyelinated. There were many regenerative clusters of myelinated 
axons and many Biingner bands. Histochemical sections revealed a large number 
of axonal swellings, similar to those seen in Patient 1 with respect to size, fre­
quency, and staining properties. Small amounts of less well organized, PAS-posi-
tive material also occurred in Schwann cells, endoneurial fibroblasts, perineurial 
cells, and occasionally around endoneurial vessels. Electron microscopy showed 
typical polyglucosan bodies predominantly in myelinated axons, but occasionally 
also in Schwann cells and fibroblasts. No amyloid was observed. Approximately 
one-fourth of the teased myelinated fibers contained one or more distensions 
similar to those in Patient 1. Two-thirds of these fibers had a normal appearan­
ce; the others showed demyelination of one or more internodes. 
Muscle and Skin Biopsy 
Muscle biopsy in Patient 2 revealed extensive type grouping and, occasionally, 
group atrophy. Nerve twigs stained with PAS showed a few polyglucosan bodies 
up to 15jLim in size located along their course. N o excess of PAS-positive mate-
Fig. 5. (Patient I) Small polyglucosan body (arrow) in dermal nerve bundle. (PASI toluidine blue stain 
of semithm section; χ 800). 
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nal was observed in muscle fibers Skin biopsy in Patient 1 revealed a few small 
polyglucosan bodies in 2 of 3 semithin sections stained with PAS (Fig 5) and in 
1 of 40 serial cryostat sections alternately stained with PAS, H&E, and plasmai 
DISCUSSION 
These patients had a slowly progressive illness characterized by upper and lower 
motor neuron involvement, sensory disturbances prodcminantly in the legs, 
neurogenic bladder, and marked involvement of the brain on radiographic exa 
mination Sural nerve biopsy showed a unique picture of axonal neuropathy 
associated with many polyglucosan bodies accumulating predominanti) but not 
exclusive!) in the myelinated axons 
A similar combination of findings has been described by Robitaille et al (2) 
in a condition called adult polyglucosan body disease (APBD) The authors 
commented on the possibility of diagnosis of this disease in life by sural nerve 
biopsy or liver biopsy Our observations confirm the usefulness of sural nerve 
biopsy in APBD, since other than in the present condition we have not seen 
similar numbers of polyglucosan bodies in sural nerve biopsies Our findings 
differ from the reported biopsies, however, in that unusually large bodies did 
not occur In fact, the size of the largest ones (}0 μηη) did not exceed the size of 
occasional polyglucosan bodies that we have observed in sural nerve axons of a 
few patients with totally different diseases, including motor neuron disease, dis­
tal motor neuronopathy, and late cerebellar cortical atrophy The latter observa­
tions stress the importance of the typical clinical history in the diagnosis of 
APBD A remarkable feature in the present two cases was the occurrence of 
polyglucosan bodies other than in myelinated axons (see Figs 2, 3) This feature, 
which we have not observed in other biopsies, was also reported by Robitaille et 
al (2) in one patient Another peculiar finding, observed in one of our patients, 
was the occurrence of polyglucosan conglomerates apparently undergoing lyso­
somal digestion in endoneunal perivascular macrophages The polyglucosan 
bodies also appeared to be present in dermal nerve twigs (see Fig 5) We are not 
sure of the diagnostic significance of this latter finding 
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ABSTRACT 
We studied three siblings and one unrelated patient with cerebrotendinous xan-
thomatosis (CTX). Of two unrelated patients, we examined biopsies of sural 
nerve, solcus muscle, and achules tendon. We also performed neurophysiologic 
investigations. Of one patient a postmortem examination of both brain and spi-
nal cord was made. It was concluded that both the central and the peripheral 
nervous system were involved in CTX, but the peripheral system only to a slight 
degree, and that the pathology was predominantly neuroaxonal rather than 
demyelinating in character. 
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INTRODUCTION 
In 1937, van Bogaert et al (3) described a patient with mental deterioration, 
cerebellar symptoms, pyramidal tract signs, mild peripheral nerve disturbances, 
juvenile cataract, and swelling of the tendons, especially the achules tendons 
The syndrome started in childhood and was very slowly progressive. They called 
this syndrome cerebrotendinous cholestanolosis or ccrebrotendinous xanthoma-
tosis In 1968, Menkes et al. (10) and Schimschock et al. (14) found that there 
was a deposition of cholestanol in several tissues. Nowadays, it is clear that there 
is an inborn error of cholesterol metabolism, which is inherited as an autosomal 
recessive trait, but there is still discussion going on about the exact nature of the 
mitochondrial defect. Although many reports on CTX are known in literature, 
there if, as far as we know, only two reports describing involvement of the 
peripheral nervous system (9, 11). 
We investigated three siblings with CTX (patients I, II and III in this study) 
and one unrelated patient (patient IV). Of patients II and IV, we took a biopsy 
of sural nerve, soleus muscle, and achules tendon. Patient I died; of him we 
made a postmortem examination of the brain and spinal cord. 
CASE REPORTS 
The clinical findings are summarized in Table 1 We were impressed bv the deterioration, cata-
ract, xanthomas, and the pyramidal tract signs The cerebellar symptoms and the disturbance of 
the peripheral nervous s\ stem were less prominent 
All patients has an increased cholestanol content in the blood and an excretion of abnormal 
bile alcohols in the urine (16) 
The neurographic findings are summarized in Table 2 The myogram of the anterior tibial 
muscle showed no abnormalities in patients III and IV, in patients I and II there were some 
broad polvphasic units at contraction We made a single fiber myogram (we used the method 
described by Stîlberg and Trontel] (15)) in patients II and IV, in patient II there was an increa-
sed fiber density (2 1, N < 1 7), in patient IV the fiber density was normal (1 Ί) The EEG showed 
in all patients a diffuse slowing without focal pathology The visual evoked potential (VHP) 
showed increased latency of PlOO in all patients The somato sensory evoked potential (SSEP), 
generated by stimulation of the median nerve at the wrist, showed a delayed cervical response in 
all patients, but the specific cortical reaction, calculated from the cervical response, had a quite 
normal latency The nonspecific cortical reaction was too late 
The CT-scan showed in all patients diffuse cortical atrophy, in patient III also cerebellar corti­
cal atrophy In patient 1 there was, moreover, a hyperdense tumor in the left cerebellar pontine 
angle, with compression of the fourth ventricle and a pronounced hydrocephalus 
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Table 1. Clinical findings in four patients with CTX 
Patient no 
II III IV 
Age 
Sex 
Age at start of deterioration 
Oligophrenia 
Cataract 
Xanthomas 
Pjramidal tract symptoms 
Cerebellar symptoms 
Peripheral nervous system 
sensory disturbance 
motor disturbance 
43 
male 
10 
+ + 
+ 
+ 
+ + + 
_ 
42 
male 
14 
+ 
+ 
+ + 
+ + 
_ 
35 
female 
10 
+ 
+ 
+ 
+ + + 
+ 
36 
male 
14 
+ 
+ 
+ + 
+ + 
+ 
Table 2. Conduction velocities (m/s) and latencies (ms) in patients with CTX 
Motor cond right 
peroneal nerve 
Distal mot latency 
right peroneal nerve 
Motor cond right median 
nerve 
Distal mot latency 
right median nerve 
Distal sensory latency 
right median nerve 
Distal sensory latency 
left sural nerve 
Patient 
I 
33 
5 5 
41 
5 3 
4 5 
4 0 
no 
II 
38 
3 2 
55 
2 6 
3 0 
37 
III 
30 
4 5 
43 
3 8 
34 
3 4 
IV 
43 
3 6 
55 
31 
3 6 
37 
Control 
5 0 5 ± 4 0 
3 4 ± 0 7 
59 ± 5 0 
3 0 ± 0 4 
2 6 ± 0 22 
3 7 ± 0 4 2 
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RESULTS 
Sural Nerve 
For the preparation of the biopsies we refer to previous reports (8). We measu­
red the total transverse fascicular area (TTFA), diminished with the area occu­
pied by Renaut bodies, and the frequency distribution of the diameters of the 
myelinated fibers. Single myelinated fibers were teased from one fasciculus and 
scored for pathologic changes (Table 3). We added to the classification of Dyck 
(6) the К fibers: spirally twisted fibers in clusters of 2-4, resulting from sprou­
ting (13). As such, these К fibers are giving a fairly good impression of the 
extent of the process of axonal regeneration. 
The fiber diameter spectrum indicated a loss of fibers in the 8-13 μιη range 
(Table 4), resulting in a unimodal curve in patient I. Regenerated axons were 
Table 3. Condition of teased myelinated fibers of sural nerve 
Patient IV 
Patient II 
Controls0 
Number 
of graded 
fibers 
98 
62 
100 
Tvpe1 of mvclmated fiber (%) 
A B C 
48 0 -
66 2 - 1 6 
98 8 0 1 
D 
3 1 
3 2 
0 2 
E 
1 0 
1 6 
0 8 
F 
6 1 
129 
0 1 
G 
10 
1 6 
Kb 
40 8 
12 9 
a
 According to Dvck (1975a) A, normal, B, irregularity of myelin sheath, C, segmental 
dcmyelmanon, D, paranodal demyehnation, E, linear rows of myelin balls (axonal degenera­
tion), F, remyelinanon, G, globules/sausages of myelin 
ь
 К fibers spirally twisted fibers as result of sprouting (see text) 
c
 Control values of midcalf sural nerves (»=13), also see Dyck (7) 
Table 4. Some morphometnc data on sural nerve biopsy of two patients 
TTFA in mirr 
Fiber density 
% fibers > 8 μηη 
Patient 
IV 
0 36 
16 200 
7 
Patient 
II 
1 04 
5 900 
18 
Age-matched controls 
» = 5 (mean [ + range]) 
0 81 (0.7-0 8) 
9 0 0 0 ( 6 600-13 400) 
24(19-31) 
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present as clusters of thinly myelinated axon sprouts, especially abundant in 
patient II, resulting in an increased fiber density in this patient. 
Some thinly myelinated (remyelinated) fibers were seen, and patient IV sho­
wed slight onion bulb formation; these observation were confirmed by electron-
microscopic examination (Fig. 1). 
Both biopsies showed a large number of Renaut bodies. Notwithstanding the 
generally accepted banal nature of these structures (2), their abundant presence 
in these two cases of CTX is a striking phenomenon. Signs of compression, sug­
gested as etiologic factor for Renaut bodies by Ortman et al. (12), were not 
Fig. 1. Sural nent. patient II (electron-microscopic examination, χ 1350). Remyeltnation (L·), onion 
hulh Γ · / and clusters ( к ) an evident. Most fibers are unaltered. 
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evident in our patients No fat-containing fibroblasts or giant cells were seen by 
light-microscopic and electron-microscopic examination We concluded that 
there was a moderately extensive chronic process of axonal degeneration with a 
good regeneration tendency, and slight signs of segmental demyelmation and 
remyelination 
Soleus Muscle 
In both patients there was a clear type-grouping with a reduction in the number 
of type II fibers (patient II 17 8%, patient IV 5 5%, the normal number of type 
II fibers in our laboratory is between 20% and 40%, with a mean of 35%) There 
was some atrophy of the fibers The subsarcolemmal succinic dehydrogenase and 
acid phosphatase activity of the type I fibers was too high In patient IV, the 
terminal innervation ratio, which is a reliable parameter for reinnervation (4), 
was increased (1 7, N = 1 1) It was concluded, therefore, that both muscles sho-
wed neurogenic disturbances with some reinnervation 
Tendon 
In both patients whe fibroblasts between the collagen fibers contained much fat, 
elsewhere the collagen bundles were thinned or had disappeared There were 
several fat-containing giant cells with sometimes 35 nuclei, with hematoxylin 
staining the fat cells had a finely foamy or roughly vacuolar aspect, and the giant 
cells had an indistinct cell membrane 
Autopsy 
The cortex was quite normal, also when neuronal contents were quantitatively 
examined, there was neither storage of lipofuscin pigment nor neurofibrillar 
degeneration 
In the cerebellum there was a loss of Purkinje cells, and in the white matter 
around the vessels there were foamy cells with storage of neutral lipids 
The globus palhdus had a quite normal structure, but at many places there 
was a storage of foamy cells (especially around the vessels) filled with neutral 
lipids (Fig 2) 
The putamen, caudate nucleus, thalamus, and hypothalamus were quite 
normal 
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Fig. 2. Globus pallidus. patient I (Luxol fast blue - cresyl violet, χ 500). Storage of neutral lipids in 
foamy cells (if) 
In the spinal cord there was a demyelination of the pyramidal tracts, spinoce­
rebellar tracts and dorsal columns. The demyelination was in the dorsal columns 
proximally more pronounced than distally, and in the pyramidal tracts distally 
more pronounced than proximally, which speaks in favor of a distal axonal dege­
neration (Fig. 3). At the brainstem level there was a big tumor in the cerebellar 
pontine angle, which proved to be a neurilemmoma. 
DISCUSSION 
Our results are in agreement with the literature, as far as the central nervous 
system (CNS) is concerned. The myelin loss in the CNS must be regarded as 
pointing to distal axonal degeneration. Also the SSEP and the VEP do not indi­
cate that there is an important contribution of segmental demyelination, and 
especially the SSEP rather points in the direction of a neuroaxonal degeneration 
(5)· 
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Fig. ЗА. В Cross section through 
medulla oblongata (A) and spinal 
cord at lumbar level (B). 
patient I (Luxol fast blue - cresyl 
violet). Λ χ 6; Β χ 10. Obvious 
demyelmation of dorsal medial 
columns (L·), more than of 
pyramidal tracts (Ш) at the level 
of medulla oblongata; at the 
lumbar level it if jutt the reverse-
99 
Most authors did not mention any involvement of the peripheral nervous 
system (PNS). Kuritsky et al. (9) mentioned affected motor and sensory con­
duction, but the disturbances were very mild. Sural nerve biopsy was not done. 
Ohnishi et al. (11) found normal conduction in ENG, but in the biopsy of the 
sural nerve they found demyelination and remyelination. Also Argov et al (1) 
reported segmental demyelination and remyelination in CTX. 
All our patients showed slightly slowed nerve conduction, which can be ascri­
bed to the loss of large myelinated fibers. The biopsy of sural nerve revealed 
relatively moderate signs of axonal degeneration and regeneration, and slight 
signs of segmental demyelination and remyelination with sporadic onion bulb 
formation. This was confirmed by electron-microscopic observation. 
CONCLUSION 
In our patients we described clinical, electrophysiologic, and histopathologic 
signs of affection of the PNS in CTX, but these signs are inconspicuous even in 
advanced cases and therefore diagnostically not important. In the pathogenesis 
of the disease neuronal factors are more important than segmental demyelina­
tion, both in the CNS and the PNS. 
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ІІІЗ 
THE DIAGNOSTIC VALUE OF SURAL NERVE 
BIOPSY IN HEREDITARY 
ATAXIAS AND SPASTIC PARAPLEGIAS 
A Study in 36 Patients 
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ABSTRACT 
Sural nerve biopsy specimens were studied in 24 patients with hereditary ataxia 
and in 12 patients with hereditary spastic paraplegia. Involvement was found in 
19 patients with ataxia, and in 4 patients with spastic paraplegia. Involvement in 
the ataxic patients consisted of 'large fiber neuropathy' in 14 patients, and mild 
reduction of large myelinated fibers with occasional evidence of axonal degene-
ration with linear rows of myelin ovoids in 5 patients. Involvement in the 4 
spastic patients consisted of mild axonal de- and regeneration. The findings are 
compared with biopsy observations reported in the literature, and the diagnostic 
value of the procedure is discussed. It is concluded that the indications for the 
biopsy are basically limited to patients with clearly abnormal sensory nerve 
action potentials. 
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INTRODUCTION 
Hereditär)' cerebellar and spinocerebellar degenerations (or heredo-ataxias) pre-
sent a large but rather cloudy collection of disorders for which no satisfactory 
scheme of classification is available at present. This lack of proper classification 
largely reflects the poor state of present knowledge regarding the specific patho-
genetic mechanisms underlying these disorders. In history, the most famous 
attempts of classifying spinocerebellar degenerations are the one by Bell and Car-
michael in 1939 (who used purely clinical criteria such as tendon reflex changes 
for subdividing spinocerebellar ataxias into Friedreich's ataxia, spastic ataxia and 
spastic paraplegia, each with a dominant and a recessive form) and the one by 
Greenfield in 1954 (who used neuropathological criteria from autopsy studies 
for subdividing heredo-ataxias into spinal, spinocerebellar and cerebellar forms). 
An up-date classification based upon clinical and genetic criteria was recently 
outlined by Harding (1983) (see Table 1). It is quite obvious, however, that any 
classification based exclusively upon clinical, genetic and neuropathological cri-
teria must inevitably fail since the criteria used lack sufficient specificity. Never-
theless, with the underlying defects still largely unknown, no better way of clas-
sification is possible at the moment 
In clinical practice, neuropathological studies for obvious reasons must be 
limited to easily accessible tissues which can be biopsied without significant 
harm. The idea that peripheral sensory nerve biopsy (a simple and relatively 
harmless procedure) might appear useful in heredo-ataxias originally came from 
observations in Basscn-Kornzweig disease (Schwartz et al. 1963) and in Frie-
dreich's ataxia (Lambert and Dyck 1968, McLeod 1969). Subsequent biopsy stu-
dies have revealed sensory nerve involvement in several other spinocerebellar dis-
eases as well. The purpose of our study is to review the abnormalities reported, 
and to discuss the diagnostic value of the biopsy. A retrospective view of our 
own experience with the procedure will be presented first. 
MATERIALS AND METHODS 
Thirty-six patients were studied 24 patients with hereditarv ataxia and 12 patients with heredita-
ry- spastic paraplegia. The recent scheme of Harding (198?) was used for classification into clini-
co-genctic entines Sural nerve biopsies were performed at midcalf level Obtained specimens 
were processed and examined according to methods described bv Joosten et al (1974) (see also 
chapter II of the present thesis) 
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Table 1. Classification of hereditar\ ataxias and paraplegias (Harding 19ЯЗ) 
Ataxias Paraplegias 
I Disorders with known metabolic 
or other cause 
A Metabolic disorders 
1 Progressive, unremitting ataxia 
Abetalipoproteinerma 
Hvpobetahpoproteinemia 
Hexosaminidase deficiency 
Glutamate dehydrogenase deficiency 
Cholestanolosis 
2 Intermittent ataxia 
Pyruvate dehydrogenase deficiency 
Hartnup disease 
Intetmittent ketoaciduna 
Deficiencies of urea cycle 
В Disorders with defective DNA repair 
Ataxia telangiectasia 
Xeroderma pigmentosum 
Cockayne syndrome 
II Disorders of unknown aetiology 
A Early onset cerebellar ataxia (CA) 
Friedreich's ataxia 
Early onset CA with retained tendon reflexes 
With hypogonadism ± deafness and/or dementia 
With congenital deafness 
With childhood deafness and mental retardation 
With pigm ret deg ± mcnt ret /dem /deafness 
With optic atrophy and ment ret (Behr) 
With cataract and mcnt ret (Marinesco Sjogren) 
With myoclonus (Ramsay-Hunt) 
X-linked recessive spinocerebellar ataxia 
CA with essential tremor 
В Late onset CA 
CA with opt atr /ophth /dem /amyotr /extrapyr 
CA with pigm ret deg ± ophth and/or extrapyr 
Pure CA with later onset 
CA with myoclonus and deafness 
Pure spastic paraplegia 
Autosomal-dominant (type I and II) 
Autsomal-recessive 
' X linked recessive 
Complicated forms of spastic paraplegia 
With amyotrophy of hands 
Resembling peroneal muscular atrophy 
Troy er syndrome 
Charlevoix-Saguenay syndrome 
Resembling ALS 
Sjogren-Larsson syndrome 
Kjelhn syndrome 
With optic atrophy ± dysarthria 
With dystonia or athetosis 
With sensory neuropathy 
Mast sy ndrome 
With cerebellar signs 
With disordered skin pigmentation 
106 
RESULTS 
A The patients with hereditary ataxia are presented in Table 2. Arrangement of 
the table is based upon nerve biopsy findings which divide these patients into 
three groups-
Table 2. Sural nerve biopsy in hereditary ataxia Observations in 24 cases 
Case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Π 
18 
19 
20 
21 
22 
23 
24 
Diagnosis 
Friedreich's ataxia (FA) 
FA 
FA 
FA 
FA 
FA 
FA 
FA 
Abetahpoprotcinenm 
Ataxia with ophthalmoplegia 
Ataxia with ophthalmoplegia 
Unclassified sensory ataxia 
Unclassified scnsor\ ataxia 
Ataxia telangiectasia (late stage) 
Ataxia telangiectasia (early stage) 
Ataxia telangiectasia (earlv stage) 
Ataxia with dementia/choreoathetosis 
Ataxia with dementia/choreoathetosis 
Ataxia with tapetoretinal dystrophy 
Ataxia with tapetoretinal dystrophy 
Ataxia with m\oclonus 
Pure cerebellar ataxia of late onset 
Unclassified cerebellar ataxia 
Unclassified cerebellar ataxia 
Age 
9 
11 
12 
13 
16 
19 
35 
51 
25 
37 
25 
20 
23 
20 
8 
10 
15 
21 
8 
17 
21 
59 
9 
10 
Sensory Tendon 
loss 
+ 
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
> 
3 
+ 
+ 
+ 
-
-
-
-
-
jerks 
_ 
-
-
-
-
-
-
-
-
-
-
-
-
-
+ 
+ 
+ 
+ 
+ + 
+ + 
+ 
+ 
+ 
+ 
M N C V 
41 
43 
51 
37 
43 
35 
41 
46 
39 
39 
41 
56 
38 
30 
44 
50 
51 
44 
47 
55 
44 
47 
48 
50 
SNAPs' 
N R 
2 
N R 
N R 
1 
N R 
N R 
N R 
-
N R 
NR 
N R 
N R 
-
-
-
4 
-
5 
10 
-
6 
8 
-
Biopsy 
find] 
LFR1 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ 
+ 
+ 
+ 
+ 
-
-
-
-
-
ngs 
A D ' 
_ 
-
-
-
-
-
-
-
-
-
-
-
-
-
+ 
+ 
+ 
+ 
+ 
-
-
-
-
-
1
 MNCV motor nerve conduction velocity (peroneal nerve) in m/sec, mean control value 50 m/s, 
range 42-58 m/s, children 8-16 yr 40-44 m/s 
2
 SNAPs amplitude of sensory nerve action potentials (sural nerve) in microvolt, mean control value 
9 μν, range 3-20 μν, NR no response obtainable, - not measured 
1
 LFR large fiber reduction 'AD axonal degeneration with linear rows of myelin balls 
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1. A large group of patients (cases 1-14) with severe reduction of large-diameter 
fibers without significant formation of regenerative clusters or onion-bulb 
structures and without the occurrence, except very occasionally, of axonal 
degeneration with linear rows of myelin balls. Patients with this type of 
involvement showed abolition of tendon reflexes, distal impairment of pro-
priocepsis (except in two cases), small or absent sensory nerve action poten-
tials (SNAPs) and normal or slightly reduced motor nerve conduction velo-
cities (MNCVs). 
2. The second group of patients (cases 14-19) showed slight loss of large-diame-
ter fibers, associated with some evidence of axonal degeneration with linear 
rows of myelin balls. Clinically, these patients differ from the first group in 
the way that they had retained tendon reflexes and low-normal amplitudes of 
the SNAPs (if studied). MNCVs in these patients were normal, while pro-
priocepsis was usually impaired (in the two patients with ataxia telangiecta-
sia, sensation could not be assessed reliably due to young age and mental 
retardation). 
3. In the third group of patients (cases 20-24) no biopsy abnormalities were 
found at all. These patients had retained tendon reflexes, normal propriocep-
sis, normally preserved SNAPs (if studied) and normal MNCVs. 
B. The patients with hereditary spastic paraplegia (HSP) are presented in Table 
3. The group consists of 4 patients with 'pure' HSP (no associated features per-
mitted, except discrete disturbances of gnostic sensation (De Coo et al. 1982)) 
and 8 patients with complicated HSP. Nerve biopsies in this group of patients 
showed little variation: normal findings in 8 cases (including all 'pure' cases) 
and mild chronic axonal de- and regeneration in the remaining 4. Those with 
normal biopsy findings had normally preserved SNAPs (if studied) and normal 
MNCVs. Despite normal biopsies, propriocepsis was found impaired in several 
of these patients (posterior column dysfunction?). The patients with chronic 
axonal neuropathy all showed impaired propriocepsis and normal or slightly 
reduced MNCVs. SNAPs were found slightly reduced in the one specifically 
studied. 
DISCUSSION 
In the hereditary ataxias (HAs), sensory nerve biopsy was first reported in 1963, 
in a study of Bassen-Kornzweig syndrome (Schwartz et al. 1963). Subsequent 
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Table 3. Sural nerve biops\ in hcreditan spastic paraplegia (HSP) Findings in 12 cases 
Nerve biops\ findings 
Sensory Normal Axonal de- and 
Case Diagnosis Age loss MNCV SNAPs regeneration 
1 'Pure' HSP (autosomal dominant type 1) 3 - 4 7 18 + 
2 'Pure'HSP (autosomal dominant t\pe II) 4 0 + 4 5 - + 
3 'Pure'HSP (autosomal dominant type II) 35 + 50 - + 
4 'Pure' HSP (autosomal recessive) 4 - Ί4 5 + 
5 Sjogren-I.arsson ssndrome 10 - 48 - + 
6 HSP with cerebellar signs 42 - 43 - + 
1
 HSP with cerebellar signs 5 1 + 4 8 6 + 
8 HSP with cerebellar signs 57 + 4 6 - + 
9 HSP with optic atroph\ 13 - 52 - + 
10 HSP with optic ¿tropin 19 + 46 - + 
11 Unclassified (with muscular hypertrophy) 25 - 39 - + 
12 Unclassified 49 + 37 2 + 
For abbreviations see Table 2 
studies have confirmed the usefulness of this relatively harmless procedure for 
studying the histopathologic features of sensory nerve involvement in these 
disorders. 
The type of involvement most frequently reported (Table 4) is large fiber 
neuropathy, which is characterized by disappearance predominantly of large-dia-
meter myelinated fibers without marked regenerative activity and writhout the 
occurrence, except very occasionally, of axonal degeneration with linear rows of 
myelin ovoids. This pattern was documented first in Friedreich's ataxia (Lambert 
and Dyck 1968, McLeod 1969) and subsequently recognised in a variety of other 
HAs as well, including abetahpoproteinemia (Miller et al. 1980), ataxia telan-
giectasia (Gardner and Goodman 1969, Jerusalem and Bischoff 1972, Schoon-
derwaldt et al. 1973), Behr's syndrome (Landrigan et al. 1973), Marinesco-Sjög-
ren syndrome (Alexianu et al. 1982), X-linked cerebellar ataxia (Spira et al. 
1979) and late onset cerebellar ataxia with ophthalmoplegia (Wadia et al. 1980, 
Scaravilli et al. 1982, Bennet et al. 1984). These observations are in accordance 
with the statement of Dyck (1984a) that neuronal atrophy affecting the extre-
mity of the distal fiber as well as the proximal fiber of primary sensory neurons 
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Table 4. Sensory nerve biopsy findings in hereditary ataxias 
Ataxias 
I Disorders with known metabolic or other cause 
A Metabolic disorders 
1 Progressive unremitting ataxia 
Abetahpoproteinemia 
Hypobetahpoproteinemia 
Hexosaminidabe deficiency 
Glutamate dehydrogenase deficiency 
Cholestanalosis 
2 Intermittent ataxia 
Pyruvate dehydrogenase deficiency 
Hartnup disease 
Intermittent ketoaciduna 
Deficiencies of urea cycle 
В Disorders with defective DNA repair 
Ataxia telangiectasia 
Xeroderma pigmentosum 
Cockayne syndrome 
II Disorders of unknown etiology 
A Early onset cerebellar ataxia (CA) 
Friedreich's ataxia 
Farly onset CA with retained tendon reflexes 
With hypogonadism ± deafness and/or dementia 
With congenital deafness 
With childhood deafness and mental retardation 
With pigm ret deg ± ment rtt /dem /deafness 
With optic atrophy and ment ret ± deafness (Behr) 
With cataract and mem ret (Marinesco Sjogren) 
With myoclonus (Ramsay Hunt) 
Literature data 
Nerve biopsy findings 
large fiber neuropathy (Miller) 
myelin breakdown and axonal degeneration' (WiUner) 
segmental de- and remyelmation (Ohmshi, Argov) 
large fiber neuropathy (Gardner, Jerusalem Schoondcrwaldt) 
global fiber loss (Thrush, Hakamada) 
segmental de- and remyelmation (Moosa) 
large fiber neuropathy (Lambert and Dyck, Mel eod) 
'minimal myelin degeneration' (Berman) 
large fiber neuropathy (Landngan) 
large fiber neuropathy (Alexianu) 
X-linked recessive spinocerebellar ataxia large fiber neuropath) (Spira) 
CA with essential tremor 
В Late onset CA 
CA with opt atr /ophth /dem /amvotr /extrapyr large fiber neuropathy (McLeod, Wadia, Scaravilli, Bennett) 
CA with pigm ret deg ± ophth and/or extrapyr 
Pure CA with later onset 
CA with myoclonus and deafness 
Table 5. Sensory nerve biopsy findings in hereditary spastic paraplegia Literature data 
Paraplegias Nerve biopsy findings 
1 Pure spastic paraplegia 
Autosomal-dominant (type I and II) reduced myelinated fiber density (Dyck), large fiber loss (Tredici) 
Autosomal-recessive 
'X-linked recessive 
2 Complicated forms of spastic paraplegia 
With amyotrophy of hands 
Resembling peroneal muscular atrophy 
Troyer syndrome 
Charlevoix-Saguenay syndrome 
Resembling ALS 
Sjogren-Larsson syndrome 
K]ellin syndrome 
With optic atrophy ± dysarthria 
With dystonia or athetosis 
With sensory neuropathy loss of myelinated and unmyelinated fibers (Cavanagh) 
Mast syndrome 
With cerebellar signs 
With disordered skin pigmentation mild reduction of mvelmated fibers (Abdallat) 
can be found in typical cases of spinocerebellar degenerations different from 
Friedreich's ataxia Additional studies have shown that involvement other than 
large fiber neuropathy can also be observed, including segmental de- and remye-
hnation in cholestanolosis (Ohmshi et al 1979, Argov et al 1982) and Cockay-
ne syndrome (Moosa and Dubowit? 1970)*, reduction of both myelinated and 
unmyelinated fibers in xeroderma pigmentosum (Trush et al 1974, Hakamada 
et al 1982) and hexosaminidase deficiency (Willner et al 1981) and 'minimal 
myelin degeneration' in cerebellar ataxia with childhood deafness and mental 
retardation (Berman et al 1973) In late onset cerebellar ataxia, one study has 
shown global reduction of myelinated fibers rather than typical large fiber neu-
ropathy (McLeod and Evans 1981), while another study (Staal et al 1981) sho-
wed clustered remyelmation without any significant fiber loss, which may repre-
sent an early stage of axonal atrophy Toghi et al (1977) have described a 
decrease of myelinated fibers (particularly affecting large fibers) in 'spinocerebel-
lar degenerations,' without specify ing, however, the clinical or pathological fea-
tures of their cases 
This large number of studies ma\ suggest that documentation of peripheral 
nerve involvement in the HAs at present is fairly complete It is quite obvious, 
however, that neither the incidence nor the full histopathologic range of this 
involvement can already be considered as assessed since adequate data in many 
disorders appear lacking (see Table) In addition it should be realized that the 
data presented in some conditions mentioned above are still scanty and, on occa-
sion, controversial 
In clinical practice, the pattern found at biopsv may not show that much 
variation, since Friedreich's ataxia and some other conditions associated with lar-
ge fiber neuropathy can be expected to account for a large proportion of index 
cases, as one can easily deduce from the frequency distribution of disorders in 
large surveys like the one presented by Harding (1983) Thus the incidence of 
this type of neuropathy in clinical practice is expected to be high, which is clear-
ly confirmed by the observations in our own series (occurrence of large fiber 
neuropathy in nearly 60% of the cases Table 2) Our study additionally suggests 
that in a significant proportion of the remaining cases only one other distinct 
pattern of involvement is found, consisting of slight reduction of large-diameter 
myelinated fibers associated with occasional evidence of axonal degeneration 
with linear rows of myelin ovoids (Table 2) Our observations also confirm pre-
* Classification of these two disorders as HAs in our view is questionable 
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vious statements (D\ck 1984a) that there are cases in which involvement, at 
least to a large extent, does not develop 
These data suggest that, in clinical practice, the diagnostic value of sensory 
nerve biopsy in HAs is very limited indeed, since the information obtained by 
the procedure is rather stereotyped and lacks any diagnostic specificity Routine 
use of biopsy in these disorders therefore has no justification In our view, the 
current value of the procedure lies basically in conditions with small or absent 
sensory nerve action potentials (SNAPs) where the findings may help in the 
differentiation between heredo-ataxia and ataxia due to hereditary peripheral 
neuropathy This differentiation, which is important in view of prognosis and 
genetic advice, may not be obtained solely be chmco-genetic criteria, motor ner-
ve conduction study or muscle biopsy Nerve biopsy in such situation may help 
to differentiate heredo-ataxia (usual biopsy finding large fiber neuropathy) from 
such disorders as the ataxic type of hereditary sensory neuropathy (biopsy severe 
loss of myelinated fibers, with smaller and fewer unmyelinated fibers Robinson 
et al 1977) and various types of hereditary motor and sensory neuropathy 
(HMSN), m particular type I (biopsy segmental de- and remyelination with 
onion-bulbs) and type II (biopsy chronic axonal degeneration with significant 
formation of clusters) Confusion with the hereditary neuropathies is not likely 
to arise, however, if the SNAPs appear normally preserved On the basis of our 
own experience we anticipate that in conditions with normal SNAPs routine 
biopsy will rarely (if ever) provide a significant contribution to the diagnosis, 
and we therefore suggest that the use of the procedure in such conditions 
should be abandoned 
With regard to nerve biopsy value in the hereditary spastic paraplegias 
(HSPs) the discussion can be short In the literature (Table 5) biopsy studies in 
these disorders appear few, suggesting that peripheral nerve involvement in the 
HSPs is much less frequent than in HA Reported findings include decreased 
myelinated fiber density (Dyck 1984b) and large fiber loss with onion-bulbs and 
clusters (Tredici and Minoh 1979) in uncomhcated HSP, loss of myelinated and 
unmyelinated fibers in HSP with ulcerating sensory neuropathy (Cavanagh et al 
1979), and mild reduction of myelinated fibers in HSP with disordered skin pig-
mentation (Abdallat et al 1980) Our material (Table 3) shows that minor 
involvement can be found in some other varieties as well In most of our 
patients, however, peripheral nerve involvement could not be demonstrated 
Though these data suggest that nerve biopsy may not be very useful in HSP, it 
is obvious that available information is as yet insufficient to permit definite con-
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Table 6. Diagnostic value of nerve biops\ in hereditary ataxias and spastic paraplegias 
Diagnostic value of nerve biopsy 
Hereditary ataxias 
With small or absent SNAPs' differentiation from HMSN/HSN1· 
With normally preserved SNAPs no value 
Hereditary spastic paraplegias 
With abnormal SNAPs still unassessed 
With normally preserved SNAPs no value 
'SNAPs = sensory nerve action potentials, bHMSN = hereditary motor and sensory neuropathy, HSN 
hereditary sensory neuropathy 
elusions. We therefore propose that additional biopsy studies in these disorders 
be performed until the full range of involvement has been assessed. In view of 
the normal biopsies in all our patients with normally preserved SNAPs, we sug­
gest that unrewarding biopsies should be prevented by limiting the procedure to 
patients with clearly abnormal SNAPs. 
The general conclusion or our study is that involvement of the peripheral 
nerves is a frequent feature in the HAs, and probably a less frequent phenome­
non in the HSPs. The histopathology of this involvement can be adequately 
studied by sural nerve biopsy. Various parterns of neuropathy have been found, 
but none of the patterns appears specific. The diagnostic value of the biopsy 
(schematically drawn in Table 6) seems limited to patients with clearly abnormal 
SNAPs. 
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Ill 4 
SURAL NERVE BIOPSY IN HEREDITARY 
MOTOR NEUROPATHY 
A study of 18 cases 
117 
ABSTRACT 
Sural nerve biopsies were studied in 18 patients with various types of hereditary-
motor neuropathy. Absence of involvement was found in 8 cases, mild axonal 
involvement in 7 cases and substantial axonal involvement in 3 cases. The find-
ings illustrate that hereditary motor neuropathy cannot be considered as a 
'pure' motor degenerations, as the peripheral sensory nerves appear frequently 
involved as well. Involvement of these nerves, however, is usually mild and in 
most cases unassociated with clinical sensory' manifestations. 
The diagnostic value of the biopsies is discussed, and it is concluded that 
performance of the procedure in the large majority of cases is diagnostically use-
less. Current use of the biopsy should be limited to patients with objective evi-
dence of sensory nerve involvement, in particular to patients with clearly abnor-
mal sensory nerve action potentials. 
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INTRODUCTION 
Hereditary motor neuropathy (HMN) designates a group of inherited disorders 
characterized by progressive muscle wasting and weakness due to degeneration 
of lower motor neurons. The subject has been reviewed recently by Harding 
(1984) who also presented an up to date classification (Table 1). 
It is usually believed that the peripheral sensory nerves in HMN remain unin-
volved. Sensory symptoms and signs are said to be absent, and sensory conduc-
tion is stated to be normal (Harding, 1984). Little attention, however, has been 
paid to histopathologic evaluation of these nerves. This is surprising in view of 
the fact that some older studies have shown definite involvement in biopsied 
nerves of typical cases (Carpenter et al. 1975; Hausmanowa-Petrusewicz et al. 
1975). 
In our present study we describe the results of sural nerve biopsy in a series of 
patients with various types of HMN, and we discuss the indications of the pro-
cedure in clinical practice. 
Table 1. Classificmon of hereditary motor neuropathy (after I larding 1984) 
Distribution and type 
Proximal 
Bulbospinal 
Distal 
Scapuloperoneal 
Facioscapulohumeral 
Oculophan ngeal 
Bulbar 
type 
t \pe 
t\pe 
type 
type-
type 
type 
type 
type 
type 
type 
type 
type 
type 
I 
II 
III 
IV 
V 
I 
II 
III 
IV 
V 
I 
II 
I 
II 
(acute infantile) 
(chronic childhood) 
(adult onset) 
(iuvenile onset) 
(adult onset) 
(juvenile onset) 
(adult onset) 
(mild juvenile) 
(severe juvenile) 
(upper limb predominance) 
(with deafness) 
(yyithout deafness) 
Inheritance 
AR 
AR 
AR 
AD 
AD 
XI.R 
AD 
AD 
AR 
AR 
AD 
AD 
AR 
AD 
AD 
AR 
AR 
AR = autosomal recessive, AD = autosomal dominant, XLR = X-linked recessive 
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PATIENTS AND METHODS 
Eighteen patients with HMN were studied (Table 2). Clinicallv these patients suffered from 
progressive muscle wasting and weakness of variable severity and distribution. Inheritance in 
most cases appeared autosomal recessive. Electromyography and muscle biopsy in all cases revea-
led evidence consistent with lower motor degeneration. 
Symptoms and/or signs of sensory nerve involvement were absent in all cases reliably testable 
Motor conduction appeared normal (12 cases: no. 2-9. 13, 14. 17 and 18) or slightly reduced (4 
cases: no. 10, 12, 15 and 16). with a lower range of 78% of mean control value. In 2 cases (no. 1 
and 11 ) no conduction could be measured owing ro rotai denervation atrophy. Sensory nerve 
action potentials were measured in 13 cases, and found normal in 10 (cases 2, 5, 6, 8-11, 13, 14 
Fig. I. Cross-section showing three clumps of myelin debris (arrows) resulting from axonal degeneration. 
Proximal HMN type I, x3,000. 
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Table 2. Clinical and nerve biopsy findings in 18 cises of hereditary motor neuropatia 
Case TypcofHMN Age Sensation' MNCV' SNAPs' Sural nerve biopsy findings 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
proximal 
distal 
bulbar 
type 
type 
type 
type 
type 
type 
type 
type 
type 
type 
type 
typcl 
typel 
t y p e ! 
typel 
type 
type 
type 
1 
1 
II 
[I 
[I 
II 
11 
II 
1 
I 
II 
II 
II 
II 
V 
2mo 
3mo 
5mo 
2 
5 
10 
10 
33 
35 
29 
58 
14 
24 
34 
55 
26 
48 
15 
? 
? 
? 
-> 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
N R 
28 
35 
44 
45 
44 
48 
46 
51 
39 
N R 
39 
46 
44 
41 
40 
48 
46 
-
10 
-
-
12 
7 
-
8 
5 
7 
4 
-
15 
8 
N R 
N R 
2 
8 
axonal degeneration 
axonal degeneration 
axonal degeneration 
normal 
normal 
normal 
normal 
normal 
occasional regenerative clusters 
clustered de- and rcmyelination (sporadic) 
occasional clusters, some Lafora bodies 
normal 
normal 
normal 
large fiber decrease, clusters 
large fiber decrease, clusters, thick myelin 
large fiber decrease, clusters, clustered de /rcmyelination 
occasional clusters 
'Sensation η = normal, ' not reliably testable 'MNCV motor nerve conduction velocity in m/sec (peroneal nerve) mean 
control value 50 m/s, range 42-58 m/s, children 1 wk-4 mo 20-24 m/s, 4 mo 1 yr 30-34 m/s, NR no response (total 
atrophy) 'SNAPs sensory nerve action potentials (sural nerve) in μν, mean control 9 μuV, range 3-20 μν, — not measu­
red, NR no response obtainable 
κ> 
and 18) and abnormal in 3 (no response obtainable in cases l'y and 16. response of reduced 
amplitude in case 17). 
Sural nerve biopsies were performed at midcalf level. Obtained specimens were examined 
according to methods described in chapter II of this thesis. 
RESULTS 
A summary of the biopsy findings is included in Table 2. As can be seen in this 
table, the biopsied nerves were normal in 8 cases (no. 4-8 and 12-14) and patho-
logically involved in 10 cases (no. 1-3, 9-11 and 15-18). 
Fig. 2. Two unmyelinated axons (A) with swollen axoplasm. including degeneration of unmyelinated 
fibers. Proximal HMN type I. x6.200. 
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Normal findings were obtained in 4 patients with proximal HMN type II 
(Kugelberg-Welander disease: cases 4-7), in one patient with proximal HMN 
type III (case 8) and in three patients with distal HMN type III (cases 12-14). 
In 7 patients with abnormal biopsies (no. 1-3, 9-11 and 18) the pathologic-
findings appeared quantitatively mild and unassociated with clinical manifesta-
tions of sensory dysfunction. In the three infants with proximal HMN type I 
(Werdnig-Hoffmann disease: cases 1-3) the findings consisted of degeneration 
of both myelinated (figure 1) and unmyelinated (figure 2) axons, with occurren-
ce of Biingner bands (figure 3). In the other patients with mild involvement, 
Fig. 3. In the endoneunum. Schwann cell complexes without myelinated or unmyelinated axons (so-called 
Büngner hands) are seen, resulting from axonal degeneration (Thomas 1969: Ochoa and Mair. 1969). 
Proximal HMN type I, 25,000. 
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Fig. 4. Occurrence of some small clusters (arrows), indicative of regeneration after degeneration (Thomas 
1968). Semithin section stained with toluidtne blue (case 9), xlOO. 
the findings consisted of occasional occurrence of regenerative clusters (cases 9, 
11 and 18: see figure 4) and sporadic occurrence of clustered remyelination in 
teased fibers (case 10: figure 5). All these findings are consistent with mild axo-
nal (or neuronal) involvement. In one case (no. 11), occurrence of clusters was 
associated with occasional occurrence of Lafora bodies (figure 6). 
Substantial involvement was found only in the three patients who had clearly 
abnormal sensory nerve action potentials (cases 15-17). Biopsies in these patients 
revealed evidence of chronic axonal involvement with clear decrease of large 
myelinated fibers (figure 7), moderately frequent occurrence of regenerative clus-
ters and, in two of them, additional features suggesting axonal atrophy: occur-
rence of relatively thick myelin sheaths in relation to axonal diameter (case 16: 
figure 8) and occurrence of clustered remyelination in teased fibers (case 17). 
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Fig. 5. Teased fiber showing multiple regioni of remyelination (case 10). xl20. A mus point to Ramier 
nodes. Occurrence of clustered del remyelination in teased fibers is suggestne of neuronal atrophy and dege-
neration (Dyck and Lais ¡97i). 
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.Bf 
Fig. 6. Lafora body in myelinated fiber (case 11). Diastase PAS. хЗОО. 
density (no./íW) 
I ' 1 — • 1 ' 1—• 1 ' — I — • 1 I——1 
β 2 4 6 8 1β 12 14 16 
diameter (μιη) 
Fig. 7. Histogram of myelinated fibers (case 15) showing decrease of large fibers. Shaded figure: control 
values. 
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Fig. 8. Fibers with thick mylin sheaths in relation to axonal diameter. This feature indicates axonal 
atrophy as a sign of neuronal degeneration (D)ck et al, 1971 J. χ 3,700. 
DISCUSSION 
Our study provides evidence that H M N cannot be considered as a 'pure' motor 
degeneration as the peripheral sensory nerves appear frequently involved as well. 
The involvement is characterized by a nonspecific and usually chronic process of 
axonal (or neuronal) atrophy and degeneration which in most cases appears 
quantitatively mild and unassociated with clinical manifestations. In our series 
of 18 biopsied patients we found evidence of sensory involvement in no less 
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Table 3. Summin of the findings 
Biopsy findings 
absence of involvement 
mild axonal involvement 
substantial ачопді involvement 
No of cases 
8 (cases 4-8 and 12-14) 
7 (cases 1-3,9-11 and 18) 
3 (cases 15-ΐη 
Sensation 
normal 
normal 
normal 
Senson potentials 
normal 
normal 
reduced amplitude 
than 10 cases, as opposed to absence of such involvement in only 8. The findings 
in our series can be summarized as follows (Table 3). 
1. absence of involvement: found in 8 patients without clinical evidence of sen­
sory nerve involvement (normal sensation and, if measured, normal sensory 
nerve action potentials). 
2. mild axonal involvement: found in 7 patients who, like the ones with nor­
mal biopsies, showed no clinical evidence of sensory nerve involvement. 
3. substantial axonal involvement· found in 3 patients with normal sensation 
but clearly reduced amplitude of the sensory nerve action potentials. 
These data already suggest that, in clinical practice, the value of sensory nerve 
biopsy in HMN will not be very high. As will be noticed, the findings in 
patients with normal sensory nerve action potentials (i.e. the large majority of 
patients in practice) either appear normal or consist of mild axonal degenera­
tion. Since neither of these two patterns provides any significant contribution to 
the diagnosis, we obviously have to conclude that performance of sensory nerve 
biopsy in most patients with HMN is diagnostically useless. This conclusion is 
not challenged by the observation of occasional Lafora bodies in one patient 
(case 11, aged 58), as occurrence of these bodies at an older age has no clear 
diagnostic significance (see discussion of chapter III 5), unless accumulation of 
massive numbers is observed (chapter III 2.1). 
In our view the current value of sensory nerve biopsy in H M N is limited to 
the occasional patients who exhibit clear clinical evidence of sensory nerve invol­
vement, like our two patients with distal H M N (cases 15 and 16) and the one 
with bulbar HMN (case 17) who all three showed reduced amplitude of their 
sensory nerve action potentials. In the two with distal H M N the biopsy findings 
appeared particularly useful in differentiating their condition from the neuronal 
type of hereditary motor and sensory neuropathy (type II HMSN: Dyck et al. 
1984). In the latter condition, the pathologic hallmark in biopsied sural nerves 
of patients with prominent motor weakness is severe axonal neuropathy with 
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loss of large-diameter fibers and occurrence of numerous regenerative clusters, 
often of very complex structure (Joostcn, 1982). Compared to the severity of 
involvement seen in such cases, axonal pathology in our present two patients 
(both showing severe atrophy and weakness of their distal muscles) appeared 
relatively mild, with only moderately frequent occurrence of regenerative clus-
ters which, in addition, showed no complexity of structure. On the basis of 
these findings, type II HMSN in both cases was considered to be excluded. In 
the patient with bulbar HMN (case 17) the finding of axonal involvement at 
biopsy may not have contributed to the diagnosis itself, but nevertheless appea-
red valuable for having documented the pathological features of sensory involve-
ment in a patient showing such unusual combination of bulbar H M N with 
clinically detectable sensory neuropathy. 
Previous pathological studies of the peripheral sensory nerves in H M N appear 
few. The reported data basically confirm our experience that the findings at 
biopsy either are normal or consist of axonal degeneration. The first data were 
presented by McLeod and Prineas (1971) who found no abnormalities in sural 
nerves of 4 patients with distal HMN. Carpenter et al. (1975) observed nume-
rous ovoids of Wallerian degeneration in biopsied sural nerves from 5 patients 
with proximal HMN type 1 (Werdnig-Hoffmann disease). In sural nerves of 4 
children with the same condition, Hausmanowa-Petrusewicz et al. (1975) found 
slight decrease of myelinated fiber density and some reduction of large fibers. 
The changes were considered to be caused either by axonal degeneration or by 
delayed myelination. In a recent study (Matsubara and Tanabe 1983), biopsied 
sural nerves of 3 patients with distal HMN were described to show a decrease in 
the number of myelinated fibers and 'various degrees of degenerative change of 
the myelin and axons'. Unfortunately, the findings in these cases were mentio-
ned only briefly, without details. 
Combining our data with those reported in the literature the conclusion 
remains that routine performance of sensory nerve biopsy in HMN is clinically 
unjustified as the information obtained in most cases provides no significant 
contribution to the diagnosis. On the basis of our own experience we suggest 
that the procedure be limited to patients with objective clinical evidence of sen-
sory nerve involvement, in particular to patients with clearly abnormal sensory 
nerve action potentials. Biopsies in such patients may appear particularly useful 
in those with distal HMN as the findings may help to differentiate their condi-
tion from HMSN type II (see our cases 15 and 16). In those with other types of 
HMN and abnormal sensory potentials, the biopsy value at present cannot yet 
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Table 4 Value of sensory nerve biopsy in HMN 
Sensory potentials Value of the biopsy 
normal no clinical value 
reduced amplitude documentation, in distal HMN differentation from 
typellHMSN 
be outlined since adequate documentation still appears to be lacking Biopsy 
studies in these patients therefore remain justified until more data become avai­
lable Table 4 summarizes our opinion with regard to the biopsy value in 
practice 
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Ill 5 
SURAL NERVE BIOPSY IN MOTOR NEURON 
DISEASE 
Observations in 10 patients, with a discussion of the 
biopsy value for the diagnosis 
ABSTRACT 
Sural nerve biopsies were studied in 10 patients with sporadic motor neuron 
disease In one patient the biopsy findings appeared entirely normal, in the 
others the findings were usually consistent with axonal atrophy and degenera-
tion which in most cases was unassociated with clinical sensory manifestations 
In three patients there was occurrence of Lafora bodies, a finding which appea-
red to have only doubtful significance In general, the findings obtained did not 
justify routine use of nerve biopsy in the diagnosis of motor neuron disease In 
patients with abnormal sensory potentials, however, the biopsy may be helpful 
in the differential diagnosis from toxic-metabolic for paraneoplastic 
polyneuropathy 
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INTRODUCTION 
Motor neuron disease (MND) or amyotrophic lateral sclerosis is a progressive 
degenerative disorder of upper and lower motor neurons, clinically characterized 
by asymmetrical muscular weakness and atrophy with hyperreflexia, beginning 
in adult life and leading to death by respiratory insufficiency in a median time of 
three years (Mulder 1984). The diagnosis usually can be made on basis of the 
clinical history, neurologic examination and electromyogram. The disorder 
occurs with a sex-ratio of 2:1, with preponderance of male. In 5-10% of all 
patients there is a positive family history suggesting a dominant inheritance 
with good penetrance (Hirano et al. 1967). In most cases, however, the disease is 
spotadic. The association of MND with other neurological disorders was recent-
ly teviewed (Hudson 1981). 
Until few years ago it was the general opinion that, except in some familial 
variants (Horton 1976), sensory disturbance in no feature of MND, and absence 
of sensory symptoms was therefore considered important in the diagnosis (Bon-
duelle 1975). Recent morphometric studies of biopsied cutaneous nerves, how-
ever, have provided evidence of mild sensory involvement, with or without 
discrete clinical manifestations, in several patients with M N D (Dyck et al. 1975; 
Toghi étal. 1977). 
The purpose of our present study is to provide additional histo-pathologic 
data of sensory involvement in MND, and to discuss the value of sensory nerve 
biopsy in the diagnosis of this disorder. 
PATIENTS AND METHODS 
Ten patients with MND were studied (see Table 1) Diagnosis in these patients was based upon 
clinical history, neurologic examination and elcctrormography The median age at the time of 
investigation was 54 years (range 35-7}) Seven of the patienrs were male, and three were female 
(in agreement with a usual sex-ratio of 2 1) In all patients there was a negative family history 
with regard to MND 
Symptoms and/or signs of sensory involvement (in particular impaired position and vibrato-
ry sense) were present in three patients (cases ί-">), and were absent in the other seven In most 
cases the conduction in motor nerves was slightK slowed (lowest value approximately 70% of 
mean control see case3) Data on sensory nerve action potentials were available in 5 patients. 
the signals appeared normal in three patients (cases 1, 5 and 9) while reduced amplitude was 
found in the other two (cases 2 and 7) 
Sural nerve biopsies were performed at midcalf level The specimens obtained were processed 
and examined according to the methods described in chapter II 
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Table 1. Clinical data and biopsy findings in 10 pjtients with motor neuron disease 
Case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Age 
35 
57 
53 
53 
68 
44 
73 
54 
42 
57 
Sex 
? 
S 
3 
s 
δ 
s 
s 
? 
s 
s 
Sensation' 
η 
η 
І 
• 
{ 
η 
η 
η 
η 
η 
Μ Ν Ο Γ 
48 
34 
32 
38 
46 
37 
36 
36 
43 
47 
SNAPs 
5 
2 ( * ) 
-
-
4 
-
2 < * > 
-
5 
-
M F D ' 
η 
η 
{ 
η 
η 
ι 
i 
η 
η 
η 
Sural nerve 
A D R ' 
+ 
+ 
+ 
+ 
+ 
+ 
biopsy 
AA' 
+ 
+ 
+ 
+ 
+ 
+ 
findings 
Lafora bodies 
+ 
+ 
+ 
' Sensation Vibration and position sense, η = normal, t =impaired, MNCV motor nerve conduc 
tion velocity (peroneal nerve) in m/s, mean control value 50 m/s, range 42 58 m/s, SNAPs senso 
ry nerve action potentials (sural nerve) in μΥ, mean control value 9 μΥ, range 3-20 μΥ, - not measu 
red,4 MFD myelinated fiber density, ^ ADR axonal de and regeneration, ' AA axonal atrophy 
d e n s i t y 
{no /mm2) 
"ïf^TH—,—, 
10 12 14 16 
diameter (urn) 
Fig. 1. Diameter histogram of myelinated fibers Cease i) showing mild decrease of large fibers Shaded 
area control values 
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RESULTS 
A summary of the biopsy findings is included in Table 1. In one patient (case 1) 
the findings appeared entirely normal. In the others, the following features 
could be observed: 
1. mildly decreased density of myelinated fibers, particularly of fibers with large 
diameter (cases 3, 6 and 7: figure 1). 
2. signs of axonal de- and regeneration (cases 2-7): occurrence of regenerative 
clusters (figure 2) and occurrence of degenerating axons (figure 3). The 
extent of axonal pathology in these cases was quantitatively mild. 
Fig. 2. Occurrence of clusters farrows), indicating regeneration after degeneration (Thomas 1968J. 
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Fig. 3. Axonal degeneration with linear rows of myelin halls (case 6). Teased fiber, ХІЮ. 
3. signs of axonal atrophy (cases 4-9): occurrence of fibers with relatively thick 
myelin sheaths (illustration: figure 8 of chapter III 4; reference: Dyck et al. 
1971) and/or occurrence of teased fibers showing multiple regions of seg­
mental remyelination (figure 4). These features were observed either in asso­
ciation with axonal de- and regeneration (cases 4-7) or as an isolated finding 
(cases 8 and 9). 
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ι I 
l i 
• 
Fig. 4. Teased fiber showing multiple regions of segmental remyelination. (case 5 J, x70. Arrows point to 
Ranvier nodes. Occurrence of clustered de/ remyelination in teased fibers is suggestive of neuronal atrophy 
or degeneration (Dyck and Lais ¡97i j . 
^ - ^ 
Fig. 5. Lafora body in myelinated fiber (case 7). Diastase PAS toluidme blue. x450. 
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4. occurrence of round to oval-shaped bodies (cases 7, 8 and 10) with a frequen­
cy of several small ones (up to 5 μτη) and/or at least one large one (up to 15 
μπι) in each longitudinal section stained with periodic acid-Schiff (PAS) after 
pretreatment with diastase (figure 5). At ultrastructural examination these 
structures showed the typical appearance of Lafora bodies (figure 6). In two 
cases (no. 7 and 8), occurrence of these bodies was associated with features of 
axonal (or neuronal) pathology; in one patient (no. 10) occurrence of these 
bodies was an isolated finding. 
Fig. 6. Electronmicrograph of PAS positive bod) showing the typical appearance of Lafora bodies (case 
7). xl 1,500. 
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DISCUSSION 
Our study provides clear evidence that sensory nerve involvement is common in 
MND Pathologically the involvement is characterized by a mild process of axo-
nal (or neuronal) atrophy and degeneration which, at least in some patients, 
may also be associated with clinical sensory manifestations These data clearly 
refute the former opinion (Bonduelle 1975) that sensory disturbance is no fea-
ture of MND, and we obviously have to accept that finding of mild sensory 
symptoms and signs is fully compatible with a diagnosis of M N D In our view, 
occurrence of sensory involvement in a 'pure' motor disorder like M N D merely 
provides another illustration that in many of the so-called system degenerations 
the disease process has only limited system specificity 
Pathologic involvement of sensory nerves in M N D has been reported in two 
previous studies Dyck et al (1975) found abnormally high frequencies of teased 
fiber abnormalities in a series of 10 biopsied cases, two of which has unequivocal 
abnormalities of touch-pressure sensation of the toe Toghi et al (1977) studied 
biopsied sural nerves of 14 patients with M N D and found a decreased mean 
density of myelinated fibers, particularly of fibers with large diameter Interes-
tingly, occurrence of Lafora bodies was mentioned in neither of these two stu-
dies in which, however, PAS staining techniques were not used In our series we 
have observed these bodies in three cases (i e in 30%) At present we have great 
doubt, however, whether this finding is of any particular significance as we have 
observed occurrence of such bodies (of similar size, frequency and ultrastructural 
appearance as those in the present series) in 16% of our total number of biopsied 
patients over 50 years of age and suffering from a large variety of neurological 
diseases (n = 157) Though the percentage in our present series is somewhat 
higher, this difference appeared to have no statistical significance (p = 0 22) 
The final question to be discussed here is whether sensory nerve biopsy in 
general is a useful diagnostic investigation in patients suspected to be suffering 
from MND On basis of the current data the answer in our view has to be 
negative since none of the reported findings provides any specific diagnostic 
contribution At present we therefore see no general indication for sensory nerve 
biopsy in MND, not even in the occasional patients who exhibit mild clinical 
sensory manifestations 
In clinical practice, measurement of the sensory nerve action potentials 
should usually suffice to evaluate the state of sensory nerve function in MND, 
and there is certainly no reason for biopsy in patients whose potentials appear 
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normally preserved. In patients with abnormal sensory potentials, however, the 
possibility of other disease causes (in particular: toxic-metabolic or paraneoplas-
tic neuropathy) should seriously be considered. In our case no. 7, for example, 
we had great difficulty in making the diagnosis of M N D as this patient presen-
ted with progressive symmetrical weakness, slightly reduced motor conduction 
and decreased amplitude of the sensory nerve action potentials. Extensive labora-
tory investigation in this patient revealed no evidence of toxic-metabolic deran-
gement or evidence of malignancy. Yet, in view of the abnormal sensory poten-
tials, great clinical doubt remained, and sensory nerve biopsy was performed. 
The biopsy findings, however, appeared relatively mild (i.e. mild in relation to 
the severity of motor weakness) and M N D was therefore considered much more 
likely than toxic-metabolic or paraneoplastic neuropathy. The subsequent clini-
cal course in this patient was relentlessly progressive, with final appearance of 
bulbar involvement. At autopsy, the typical features of M N D (with some dege-
neration of the posterior columns) were found, without any other remarkable 
findings (in particular: no hidden malignancy). 
In view of this observation we believe that performance of sensory nerve 
biopsy in patients suspected to suffer from M N D at present may still be valuable 
when reduced amplitude of the sensory potentials is found (as also in our case 
2). Finding of relatively mild involvement at biopsy in such cases favours the 
diagnosis of M N D ; finding of prominent involvement, however, should raise 
serious doubt about this diagnosis and should restart a vigorous search for a 
toxic-metabolic or paraneoplastic condition. Table 2 summarizes our opinion. 
Table 2. Diagnostic value of sensory nerve biopsy in motor neuron disease 
Sensory nerve action potentials 
normal 
reduced amplitude 
Value of the biopsy 
no value 
differentiation from toxic-metabolic 
or paraneoplastic neuropathy 
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Ill 6 
SURAL NERVE BIOPSY IN 
HEREDODEGENERATIVE 
EXTRAPYRAMIDAL DISEASES 
Observations in 20 patients, with a discussion of the 
biopsy value for the diagnosis 
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ABSTRACT 
Sural nerve biopsies were studied in 20 patients with various heredodegenerative 
extrapyramidal diseases In 8 patients the biopsies were entirely normal, in the 
others the findings usually consisted of mild axonal degeneration and atrophy, 
with or without mild decrease of m\elinated fiber density Additional features 
included occurrence of spheroids in a patient with Hallervorden-Spatz disease, 
and occurrence of Lafora bodies in 3 other patients The findings illustrate that, 
in extrapyramidal system degenerations, the peripheral sensory nerves are fre-
quently involved, indicating that the process of degeneration in these disorders 
has only limited system specificity Our findings did not, however, justify routi-
ne use of nerve biopsy in these disorders as the information obtained did usually 
provide no significant contribution to the diagnosis In current practice, perfor-
mance of the biopsy in these disorders should be limited to patients with clearly 
abnormal sensory nerve action potentials 
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INTRODUCTION 
The extrapyramidal disorders constitute a large group of conditions in which 
the extrapyramidal symptoms may either be primary - i.e. the initial manifesta-
tion of the intrinsic disease process, or secondary — i.e. a later manifesta-
tion of another disease or the consequence of an identifiable extrinsic process 
(see classification of the Ad hoc Committee of the World Federation of Neuro-
logy, 1981). Since the disorders with primary symptomatology often have a clear 
genetic basis and are frequently associated with degenerative processes in distinc-
tive areas of the central nervous system, these disorders are often referred to as 
'heredodegenerative', a denomination which is inaccurate (as several disorders 
without clear evidence of heredity and/or degeneration thus become included 
under this heading: Table 1) but nevertheless firmly established in clinical usage. 
Up to the present, few reports have documented an association of extrapyra-
midal degenerative disease with peripheral neuropathy (review: Thomas 1984). 
Our first experience with such an association dates back to 1972 when we stu-
died a patient with Huntington's chorea who showed clinical features of neuro-
pathy, confirmed by clear abnormalities at nerve biopsy. Since that observation it 
has been our practice for some years to include sensory nerve biopsy in the eva-
luation of patients with heredodegenerative extrapyramidal diseases in the hope 
that this investigation might appear useful in the diagnosis. In the present study 
we describe our results, and we discuss the diagnostic value of the biopsy. 
Table 1. Classification of heredodegenerative extrapyramidal disorders 
Akinetic-rigid s\ndromes Dyskinesias 
Parkinson's disease Familial essential tremor 
Multiple system atrophy Huntington's chorea 
including Shy -Drager s\ndrome Benign hereditan chorea 
Progressive supranuclear palsy Chorea-acanthocvtosis 
Wilson's disease Essential myoclonus 
Hallervorden Spat¿ disease Elementary tics 
Pallidal system atrophy (Hunt) Tourette disease 
Fahr's disease Torsion dystonia 
Classification compiled from the paper of Marsden (1982) and the paper of the Ad hoc Com-
mittee of the World Federation of Neurology (1981 ) 
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PATIENTS AND METHODS 
Twenty patients with various heredodegcnerativc extrapmmidal diseases were studied (see Table 
2) In most patients the diagnosis was made on basis of clinico-genetic criteria Autopsy studies 
(confirming the diagnosis) were eventually obtained in the two patients with Hallervorden-
Spatz disease and in one patient with Huntington's chorea In the patient with Fahr's disease 
there were extensive symmetrical strio-pallido-dentate calcifications on CT scan In all patients 
studied, extensive laboratory investigations were carried out to exclude other disease causes 
Mean age at examination was 43 5 \ears (range 4-69) Sensation, including position sense and 
vibratory sense, was normal in all cases except one (no 3) Motor conduction was normal in 18 
cases and slightly slowed in two (no 3 and 11) Sensory nerve action potentials were measured 
in 10 cases and found invariably normal 
Sural nerve biopsies were performed at midcalf level The specimens obtained were processed 
and examined according to the methods described in chapter II of this thesis 
RESULTS 
A summary of the biopsy findings is included in Table 2. In 8 patients (no. 6-8, 
12-15 and 20) the findings appeared entirely normal. In the others, the follo­
wing features could be observed· 
1. mildly reduced density of myelinated fibers, particularly of fibers with large 
diameter (no. 2, 10 and 17: figure 1). 
densi tv 
(no /mm )^ 
3000 
, I M I 1 Μ Μ Π Ί - , , 
β 2 4 6 8 Ι« 12 14 16 
diameter Im) 
Fig. 1. Histogram of myelinated fibert (case 10) showing mild decrease of large-diameter fibers Shaded 
area: control values 
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Table 2. Clinical and nerve biopsy data in 20 patients with extrapyramidal disease 
Sural nerve biopsy findings 
Case Diagnosis Age Sensation1 MNCV' SNAPs1 MFD' ADR'' AA' Spheroids Lafora 
bodies 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
N 
15 
16 
17 
18 
19 
20 
Parkinson 
Parkinson 
Shv-Drager 
Supranuclear palsy 
Hallervorden-Spatz 
Hallervorden-Spatz 
Fahr 
Huntington 
Huntington 
Huntington 
Huntington 
Huntington 
Torsion d) stoma 
Torsion dystonia 
Torsion dystonia 
Torsion dystonia 
Torsion dystonia 
Unclassified 
Unclassified 
Unclassified 
51 
57 
56 
69 
27 
19 
42 
8 
43 
52 
64 
65 
4 
7 
10 
20 
56 
44 
36 
40 
η 
η 
i 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
42 
50 
39 
47 
45 
38 
46 
48 
45 
44 
40 
44 
50 
48 
46 
47 
43 
49 
50 
42 
-
-
-
-
-
12 
-
16 
12 
4 
5 
8 
-
12 
-
-
3 
8 
18 
_ 
η 
i 
η 
η 
η 
η 
η 
η 
η 
Ι 
η 
η 
η 
η 
η 
η 
i 
η 
η 
η 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ + 
+ 
+ 
+ 
' Sensation (position and vibration sense), η = normal, | = impaired, 2 MN'CV motor nerve conduction velocity (peroneal nerve) 
in m/s, mean control value 50 m/s, range 42-58, children 3-16 yr 40-44, ' SNAPs sensory nerve action potentials (sural nerve) in 
μΥ, mean control value 9 μΥ, range 3-20 μΥ, - not measured, ' MFD myelinated fiber density, ' ADR axonal de- and regenera­
tion, '' AA axonal atrophy, + present 
2. evidence of axonal de- and regeneration (no. 1-4, 10 and 16-19): occurrence 
of regenerative clusters and/or occurrence of degenerating axons. In all these 
cases the extent of axonal involvement appeared quantitatively mild. 
3. signs of axonal atrophy (no. 9-11, 17 and 18): occurrence of fibers with relati­
vely thick myelin sheaths and/or occurrence of teased myelinated fibers sho­
wing multiple regions of segmental remyelination. These features were obser­
ved either in association with axonal de- and regeneration (no. 10. 17 and 18) 
or as an isolated finding (no. 9 and 11). 
4. infrequent occurrence (in case 5, a patient with autopsv-proved Hallcrvorden-
Spatz disease) of fusiform axonal swellings reacting strongly positive in dehy­
drogenase stains (figure 2). At electron microscopy these structures were not 
found (owing to their infrequent occurrence). 
5. occurrence of round to oval-shaped bodies (cases 3, 11 and 19) with a fre­
quency of several small ones (up to 5 μπι) and/or at least one large one (up 
to 15 μιτι) in each longitudinal section stained with periodic acid-Schiff 
(PAS) after pretreatment with diastase. At electron microscopy these structu-
•4 
" \ 
SM • 
Fig. 2. Fusiform Uructure. ilrong/) positive m dehydrogenase stains (case "}). NADU tetrazolium reduc­
tase. x400. 
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res showed the typical appearance of Lafora bodies Occurrence of these 
bodies in all three patients was associated with evidence of axonal de- and 
regeneration 
DISCUSSION 
Our study shows clearly that the peripheral nervous system becomes frequently 
involved in heredodegenerative extrapyramidal disorders This observation corro-
berates our experience in other CNS degenerations (see previous chapters) that 
the disease process in this type of disorders is rarely confined to one specific 
system 
Involvement of the peripheral nerves in our patients with extrapyramidal 
degeneration appeared usually mild and unassociated with clinical manifesta­
tions Pathologically the involvement in most cases was characterized by axonal 
degeneration and atrophy, sometimes associated with mild reduction of myelina­
ted fiber density with predominant decrease of large fibers Occurrence of this 
type of involvement was observed in various different conditions in our series, 
without specific relation to any particular disorder 
Two observations in our series deserve special comment First there is the 
occurrence of fusiform axonal swellings in one patient with Hallervordcn-Spatz 
disease (case 5) Though the ultrastructural appearance of these swellings was 
not identified in this particular case, we are fairly confident that they represent 
spheroids as, in biopsied sural nerves of occasional patients with other diseases, 
we have observed similar structures which showed identical staining properties 
and, at electron microscopy, showed the typical appearance (Lampert 1967) of 
spheroids Since the finding of these structures, however, has no specific diag­
nostic significance (review Aicardi and Castelein 1979) it is obvious that occur­
rence of this feature has to be interpreted in relation to the clinical picture On 
the basis of the findings in our autopsy-proved case we believe that occurrence 
of spheroids in sural nerve axons, if observed within the appropriate clinical set­
ting, can provide a major contribution in the diagnosis of Hallervorden-Spatz 
disease The value of biopsy in this condition, however, seems rather limited as 
occurrence of these structures is not found in all cases, as demonstrated bv the 
negative findings in our case 6 and also in a patient reported in literature (Doo-
hng et al 1974) In addition, there is evidence from observations in a related 
disorder (i с neuraxonal dystrophy) that presence of spheroids is found more 
easily in terminal axons such as obtained in muscular end-plate biopsies (Bérard-
149 
Badier et al 1971, Martin and Martin 1972) or in biopsies of skin or conjuncti-
val tissue (Arsenio-Nunes and Goutières 1978) In view of these data we believe 
that, also in Hallervorden-Spatz disease, terminal nerve biopsy (which was not 
performed in our cases) ma) appear more useful than sural nerve biopsy, but 
evidence to support this view still has to be presented 
The second feature which deserves comment is the occurrence of occasional 
Lafora bodies, obseved in a patient with Shy-Drager syndrome, in one of the 
patients with Huntington's chorea and in one patient with unclassified extrapy-
ramidal disease (cases 3, 11 and 19) As we have already discussed in the chapter 
on motor neuron disease (III 5) we have great doubt whether occasional occur-
rence of these bodies has any particular significance and we therefore believe 
that, also in the three present cases of extrapyramidal degeneration, this feature 
has no diagnostic relevance 
Previous pathologic studies on peripheral nerve involvement in heredodege-
nerative extrapyramidal diseases appear few In chorea-acanthocytosis syndrome, 
a condition which is characterized by chorea, acanthocytosis and clinical features 
of neuropathy, nerve biopsies have shown a loss of large myelinated fibers 
(Ohmshi et al 1981) In familial extrapyramidal disease with peripheral neuro-
pathy, one older report has mentioned demyehnation at biopsy (Ziegler et al 
1972) while a more recent study described axonal loss rather than demyehnation 
in a patient with absence of sural sensory action potentials (Byrne et al 1982) 
Though limited in number, these studies confirm our experience that nonspeci-
fic involvement of peripheral nerves can be found in extrapyramidal 
degenerations 
The final point to be discussed is the usefulness of nerve biopsy in heredode-
generative extrapyramidal disease Considering all previous data we believe that 
performance of biopsy in these disorders generally has no justification as the 
information obtained by the procedure in most cases provides no significant 
diagnostic contribution Before reaching definite conclusions, however, we must 
realize that virtually all biopsy observations were made in patients who had 
normal sensory nerve action potentials Since usefulness of the procedure in 
patients with abnormal sensory potentials (who will probably be rare) at present 
cannot yet be considered excluded, we suggest that additional biopsies may be 
performed in cases with clinical neuropathy (for documentation of pathology) 
until more definite conclusions can be drawn No clear statement at present is 
possible with regard to the value of sural nerve biopsy in patients on clinical 
suspicion of Hallervorden-Spatz disease (see discussion above) Our present 
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Table 3 Indications for nerve biopsy in heredodegcnerative extrapyramidal disease 
Sensory nerve action potentials Indication for biospy 
normal no indication 
reduced implitude documentation of pathology 
view, however, is that occurrence of spheroids in this condition is better looked 
for in terminal axons of skin or conjunctival tissue, and that performance of 
sural nerve biopsy in this condition is probably not justified Table 3 summari­
zes our opinion 
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In the previous chapters we have presented a retrospective analysis of sural nerve 
biopsies in 176 patients suffering from heredodegenerative disorders with promi­
nent or exclusive involvement of the CNS. The analysis was undertaken in order 
to answer the following three questions: 
A. What is the contribution of sural nerve biopsy in the diagnosis and classifi­
cation of these disorders? 
B. What is the contribution of the biopsy in providing further insight into the 
pathology and pathophysiology of these disorders? 
C. What are the current indications for the procedure? 
ad A: 
With regard to the first question, no satisfying answer can be found in the lite­
rature as no systematic study has been devoted to this subject and as no biopsy 
data of a large consecutive series of patients have ever been presented. Our own 
series therefore provides the very first large-scale illustration of the applications 
and limitations of the biopsy in clinical practice. As shown in Table 1, the diag­
nostic contribution of the biopsy in our series was positive and specific in 30% 
of the cases, positive but not specific in 9%, and negative in 61%. Considered per 
category of patients, the contribution shows marked variation. Specific informa-
Table 1. Diagnostic results of the entire series 
POSITIVE 
specific 
-І9 (60%) 
2 (20%) 
0 
0 
0 
0 
nonspecific 
1 ( 1%) 
2 (20%) 
9 (25%) 
2 (11%) 
2 (20%) 
1 ( 5%) 
ΧΕΙ 
32 
6 
I 7 
16 
8 
19 
З Л Т І Е 
(УМ) 
(60%) 
(^%) 
(89%) 
(80%) 
(95%) 
Diffuse cerebral degenerative disorders (children) 
Diffuse cerebral degenerative disorders (adults) 
Hereditan ataxias and spastic paraplegias 
Hereditär) motor neuropath\ 
Motor neuron disease 
Heredodegenerative extrapyramidal disorders 
5S (ВД%) 15 ( 9%) 108 (61%) 
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non, for example, is obtained only in patients with diffuse cerebral degenerative 
disorders, while positive but nonspecific information is found mainly in the 
other categories (usually in a low percentage of cases) 
By far the best results are obtained in children with diffuse cerebral degenera­
tive disorders (chapter III 1), a category in which up to 60% of the biopsies may 
be positive (in our material a specific contribution in 49 cases, and a positive 
but nonspecific contribution in a case of Lafora's myoclonus epilepsy) A 
somewhat lower percentage of positive biopsies is obtained in adults with dif­
fuse cerebral degenerative disorders (in our material a specific contribution in 2 
patients with adult metachromatic leukodystrophy, and a positive but nonspeci­
fic contribution 2 patients with adult polyglucosan body disease III 2 and III 
2 1) In the hereditary ataxias and spastic paraplegias (III 3) a positive contribu­
tion is obtained only in ataxic patients with low amplitude sensory potentials 
(differentiation from HMSN and HSN) In hereditary motor neuropathy (III 4) 
the diagnostic contribution of the biopsy is usually negative, except in patients 
with distal H M N and low amplitude sensory potentials (differentiation from 
HMSN type II) In motor neuron disease (Ш 5) a positive contribution may be 
obtained only in the occasional patient with low amplitude sensory potentials 
(differentiation from toxic-metabolic or paraneoplastic polyneuropathy) The 
most disappointing results are obtained in patients with heredodegenerative 
extrapyramidal disorders (III 6), a category in which we have observed only one 
positive contribution (occurrence of spheroids in a patient with Hallervorden-
Spatz disease) in 20 biopsied cases 
From these data we can conclude that sural nerve biopsy can provide a posi­
tive diagnostic contribution in at least a significant proportion of patients with 
heredodegenerative disorders of the CNS Unfortunately, however, the number 
of patients with a positive contribution is much smaller than the number with a 
negative contribution Obviously this implies that nerve biopsy alone provides 
no useful basis for diagnosis and classification of these disorders, and that perfor­
mance of this procedure deserves no routine place in the evaluation of these 
conditions In fact, even in disorders in which a specific contribution can be 
obtained, routine performance of the biopsy appears no longer indicated, since 
alternative and less invasive diagnostic techniques are now usually available (see 
discussion of chapters III 1 and III 2) In view of these considerations it is 
obvious that the current diagnostic indications for sural nerve biopsy in these 
disorders have become very few Our suggestions with regard to the current 
indications are presented below (point C) 
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ad В: 
With regard to the second question, the available literature once again provides 
no satisfying answers. Detailed information is available only in a small number 
of well-known conditions, such as Friedreich's ataxia (Dyck and Lambert 1968, 
McLeod 1971, Ouvrier et al. 1982, Caruso et al. 1983), metachromatic leukodys­
trophy (Dayan 1967, Joosten et al. 1975, Percy et al. 1977, Thomas et al. 1977, 
Martin et al. 1982) and globoid cell leukodystrophy (Lake 1968, Bischoff and 
Ulrich 1969, Hogan et al. 1969, Lyon et al. 1971, Joosten et al. 197Ί). No syste­
matic information, however, has ever been presented as to how often the PNS 
generally becomes involved in heredodegenerative disorders of the CNS, which 
patterns of PNS involvement can be found, and which mechanisms are responsi­
ble for the development of clinical symptoms. 
The frequency of PNS involvement in these disorders can be illustrated by 
referring to the findings in our own series (Table 2), in which abnormal biopsies 
occurred in 122 cases (69%) from all the various categories. This high figure 
illustrates clearly that the PNS in these disorders is very frequently involved and 
that the process of degeneration affecting the CNS in most of these disorders 
has only limited system specificity. Even in 'pure' motor degenerations such as 
hereditary spastic paraplegia, hereditary motor neuropathy and motor neuron 
Table 2. Summary of biopsy findings in the entire series 
Total No of 
no of abnormal 
Category of patients 
Diffuse cerebral degenerative disorders 
(children) 
Diffuse cerebral degenerative disorders 
(adults) 
Hereditary ataxias and spastic paraplegias 
Hereditan motor neuropathy 
Motor neuron disease 
Heredodegenerative extrapyramidal disorders 
biopsies 
82 
10 
36 
18 
10 
20 
biop 
58 
9 
23 
10 
8 
13 
122 
síes 
Cl5f) 
(90%) 
(64r/r) 
(5690 
(80%) 
(659?) 
(699?) 
SD1 
49 
2 
0 
0 
0 
0 
51 
SDR' 
19 
2 
0 
0 
0 
0 
21 
A N ' 
12 
7 
23 
10 
8 
12 
^2 
L 
1 
2 
0 
1 
3 
3 
10 
S' 
0 
0 
0 
0 
0 
1 
1 
SD specific deposits; ' SDR· segmental de- and remyelmation; ' AN axonal neuropathy, 
L Latora bodies, * S spheroids 
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disease, the peripheral sensory nerves appear to be regularly involved, though the 
extent of involvement is usually mild and rarely associated with clinical sensory 
dysfunction 
The abnormalities at biopsy in our series showed remarkably little variation 
(Table 2) The findings consisted of the following 5 basic features, occurring 
either alone or in combination specific deposists (51 cases), segmental de- and 
remyelination (21 cases), axonal neuropathy (72 cases), occurrence of Lafora 
bodies (10 cases) and occurrence of spheroids (1 case) Specific deposits and seg-
mental de- and remyelination appeared to occur exclusively in patients with dif-
fuse cerebral degenerative disorders Axonal neuropathy (the most frequent fea-
ture) was observed in patients from all desease categories In most cases the 
extent of axonal involvement appeared only mild, severe involvement was found 
particularly in ataxic patients with sensory potentials of low amplitude (III 3) 
Occurrence of Lafora bodies, either as an isolated finding (2 cases) or associated 
with axonal neuropathy (8 cases), was observed in 10 patients from various dis-
ease categories Except in two patients with adult polyglucosan body disease (III 
2 1) and in one patient in with Lafora's myoclonus epilepsy (III, 1), the occur-
rence of these bodies appeared to have no diagnostic significance (see discussion 
III 5) Occurrence of spheroids was observed only on one single occasion (in a 
patient with Hallervorden-Spatz disease) 
These data illustrate that the pattern of peripheral nerve involvement in CNS 
degenerations is relatively stereotyped as, with the exception of highly variable 
specific deposits, only few different histopathologic features are observed In 
order to analyze the role of these features in producing clinical symptoms, we 
have to compare the various biopsy patterns (i e the 5 basic features and the few 
combinations in which they occurred) with presence or absence of clinical neu-
ropathy see Table 3 As is evident from this table, the development of symp-
toms can be explained only by the features of axonal neuropathy and segmental 
de- and remyelination, as isolated occurrence of specific deposits, Lafora bodies 
or spheroids appeared unassociated with clinical neuropathy It is also shown 
that the number of cases with clinical neuropathy is much smaller than the 
number of cases with abnormal biopsies This illustrates that pathologic involve-
ment in many cases is quantitatively mild and unassociated with clinical 
manifestations 
The conclusion from this part of the discussion is that sural nerve biopsy has 
definitely enriched our insight into the pathology and pathophysiology of here-
dodegenerative disorders of the CNS First the procedure has demonstrated ven 
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Table 3. Correlation between biops\ pattern and occurrence of neuropath\ 
Biops\ pattern No No of cases with 
clinical neuropath\ 
axonal neurop.uliv 
axonal neuropath\ + Lafora bodies 
axonal neuropathy + specific deposits 
segmental de/remvelination + specific deposits 
specific deposits 
Lafora bodies 
Spheroids 
60 
8 
4 
21 
26 
2 
1 
122 
28 
6 
4 
21 
0 
0 
0 
59 
( 47%) 
( 75%) 
(100%) 
(100%) 
(48%) 
clearly that the process of degeneration in these disorders has only limited sys-
tem specificity and frequently involves the PNS as well. Secondly the procedure 
has demonstrated that the pattern of PNS involvement in these disorders shows 
remarkably little variation. Thirdly the procedure has demonstrated that devel-
opment of clinical symptoms has to be explained on basis of axonal or segmen-
tal de- and remyelinating neuropathy. 
adC: 
The final part of our discussion concerns the current indications for biopsy. Sin-
ce these indications already have been discussed in the various chapters of our 
study, we shall present here only the conclusions. Before that, however, it may 
be useful to recall the two major restrictions for biopsy that have emerged from 
our study. The first and probably most practical restriction is that biopsy should 
not be performed in patients without objective clinical neuropathy, as the yield 
of the procedure in such patients is insufficient to justify the investigation. The 
second restriction concerns the patients with diffuse cerebral degenerative dis-
orders, implying that performance of nerve biopsy in these patients should never 
be considered when skin or conjunctival biopsy has not yet been performed. 
For the various disease categories the current indications can be summarized 
as follows: 
1. in children with diffuse cerebral degenerative disorders (III 1) performance of 
nerve biopsy at present is indicated only in the occasional patient with clini-
cal neuropathy in whom all other investigations (including skin or conjuncti-
val biopsy) have failed to provide a definite diagnosis. 
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With such limitation the indications for biopsy in this category of patients 
become ver\ rare indeed, though it should be remembered that biopsy on 
occasion is still useful even in disorders which are now diagnosed by enzyme 
assay For example, we have demonstrated that biopsy on occasion may be 
helpful in correcting false positive or false negative diagnosis of MLD in 
patients with low ar\lsulphatase A activity (III 1 1) 
We have also demonstrated, in a case of globoid cell leukodystrophy, that 
the biopsy can help to confirm the diagnosis in a patient with an atypical 
clinical presentation (III 1 2) 
In suspected Cockayne syndrome (III 13) performance of the biopsy in our 
view is still justified as the finding of segmental dc- and remvclination in 
combination with typical deposits still provides a valuable contribution to 
the diagnosis 
2 in adults with diffuse cerebral degenerative disorders (III 2) the same gui-
deline can be used as in children with such disorders The most useful appli-
cations in adults have been obtained in metachromatic leukodystrophy (con-
firmation of enzyme diagnosis) and adult polyglucosan body disease (see IV 
2 1) In general, biopsies in this category of patients remain indicated in any 
unclassified patient with clinical features of neuropathy, including clearly 
abnormal SNAPs 
3 in the hereditary ataxias and spastic paraplegias (III 3) the diagnostic value of 
nerve biopsy appears rather limited The main application is found in ataxias 
with small or absent SNAPs where the biopsy may help in the differentiation 
from ataxia due to hereditary motor and sensory neuropathy (HMSN) or ata-
xia due to hereditary sensory neuropathy (HSN) In spastic paraplegia, perfor-
mance of biopsy in most cases is probably useless Additional biopsy studies 
in cases with clearly abnormal SNAPs remain indicated, however, until more 
definite conclusions can be drawn 
4 in hereditary motor neuropathy (III 4) performance of nerve biopsy should 
be consideied particularly in patients with distal HMN and low amplitude 
sensory potentials (differentiation from HMSN type II) In patients with 
other types of HMN and low amplitude SNAPs the biopsy is useful for 
documentation of the neuropathy 
5 in motor neuron disease (III 5) no plain indication for senson nerve biopsy 
is found, except in the occasional patients with low amplitude sensory poten-
tials Biopsy in such patients may help in the differentiation from toxic-meta-
bolic or paraneoplastic polyneuropathy 
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Table 4. Indications for sural ner\e biops\ in hcredodegenerative disorders of the CNS 
Category Indication for biops\ 
Diffuse cerebral degenerative disorders 
(children and adults) 
Hereditär) ataxias 
No indication, except in occasional patients 
with overt neuropathy when all other investiga 
lions (including skin or conjunctival biopsy) 
have been untcwarding 
Biopsy indicated in conditions with small or 
absent SNAPs when reliable differentiation 
from HMSN or HSN cannot be obtained on 
basis of other criteria 
Hereditary spastic paraplegia 
Hereditary motor neuropathy 
Motor neuron disease 
Hcredodegenerative extrapyramidal disorders 
No indication for biops), except in the occasio 
nal patient with small or absent SNAPs (docu-
mentation of pathology) In distal HMN with 
low amplitude SNAPs differentiation from 
HMSN type II In MND with low amplitude 
SNAPs differentiation from toxic metabolic or 
paraneoplastic polyneuropathy 
in hcredodegenerative extrapyramidal disorders (III 6) no useful indication 
for biopsy until now has been presented Additional biopsy studies in 
patients with small or absent SNAPs remain justified, however, until definite 
conclusions can be drawn If demonstration of spheroids is pursued, biopsy 
of conjunctiva or skin should be preferred as these structures are better looked 
for in terminal nerve twigs 
With the previous considerations we hope to have provided a useful scheme of 
indications (for summary see Table 4) for sensory nerve biopsy in hcredodege-
nerative disorders of the CNS By using this scheme as a reference we believe 
that the diagnostic yield of the procedure can be improved and that unnecessary 
or unrewarding biopsies can be largely avoided In addition we believe that this 
scheme can serve as a practical guideline for clinicians in deciding which patient 
might be referred for biopsy 
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Obviously, the presented scheme should not serve as a static guideline, but 
rather should be modified and changed by future biopsy observations and by 
future developments in the field of diagnostic approach With further progress 
in clarifying the specific defects underlying these disorders, the indications for 
biopsy can be expected to become progressively rare until, finally, diagnostic per-
formance of the procedure in these disorders may become totally abandoned 
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SUMMARY 
Sural nerve biopsies in 176 patients with heredodcgenerative disorders of the 
central nervous system (CNS) were studied in retrospect The purpose of the 
study was to evaluate the contribution of nerve biopsy to the diagnosis and clas­
sification of these disorders, and to analyze the information which the biopsy 
provides about the pathology and pathophysiology of these disorders In addi­
tion, the study was undertaken in order to investigate the question of what indi­
cations for biopsy in CNS degenerations at present remain, particularly in view 
of recent developments in the diagnostic approach 
The studied patients were subdivided into 6 clinical categories 
1 diffuse cerebral degeneration (children) 82 cases 
2 diffuse cerebral degeneration (adults) 10 cases 
3 hereditary ataxia (ΗΛ) and spastic paraplegia (HSP) 36 cases 
4 hereditary motor neuropathy (HMN) 18 cases 
5 motor neuron disease (MND) 10 cases 
6 extrapyramidal degeneration 20 cases 
In the studied material, involvement at biopsy was found in 122 cases (69%) 
The features of this involvement, however, appeared diagnostically significant in 
only 68 cases (39%), most of them suffering from conditions in which the diag­
nostic approach is currently based upon less invasive procedures In view of this 
it had to be concluded that the value of nerve biopsy in CNS degenerations at 
present has become rather poor indeed, and that performance of the procedure 
in general provides no useful contribution to the diagnosis and classification of 
these disorders 
In the 122 cases with involvement at biopsy, the findings consisted of axonal 
degeneration (n = 72), segmental de- and remyelmation (n = 21), specific 
deposits (n = 51), Lafora bodies (n = 10) and spheroids (n = l) In 59 cases 
(34%) there was clinical evidence of neuropathy, invariably explained by axonal 
or segmental dc- and remyelmating alterations at biopsy 
These data illustrate that the process of degeneration in heredodcgenerative 
disorders of the CNS has only limited system specificity, as involvement (specif­
ic or nonspecific) of the peripheral nervous system is frequently observed as well 
Clinical manifestations of latter involvement develop solely by axonal or seg­
mental demyelinating pathology 
The current indications for nerve biopsy in CNS degenerations appear basical-
165 
ly limited to patients with clear clinical evidence of neuropathy (including small 
or absent sensory nerve action potentials), when all other investigations have 
failed to provide a definite diagnosis A summary of the indications is presented 
in the figure below 
SCHFMb ОЬ 1 Ы Ж ATIONS TOR SI RAL \ I RVF BIOPSY IN HI RI DODFGbNI RATIVF 
DISORDIRSOI I H ! CINTRAI M RVOl'S SYS1I M 
no noication lor biopsy • no clinical neuropathy 
normal SNAPs 
no indication (or biopsy 
STiaM or absent SNAPs 
• 
biopsy useful lor documental ion 
ol peripheral n<>rve pathology 
normal S^APs 
no indication for biopsy 
STiall or absent SNAPs 
* 
biopsy indicated lor dill°rential>on from tome 
metabolic or paraneoplastic polyneuropathy 
overt neuropalhy + biopsy indicated only fthen all 
oth»r investigations iincludinq 
skin or conjunctival biopsy ι 
have been unrewarding 
mal SNAPs • no indication 
SNAPs small or absent • biopsy indicated when 
reliable diftlerenhation Irom HMSN or HSN 
cannot be obtained on basis ol other criteria 
normal SNAPs • no indication 
SNAPs small or absent • biopsy useful for 
documentation ol sensory nerve pathology 
normal SNAPs 
• 
no indication for biopsy 
small or absent SNAPs 
• 
m distal HMN differentiation from HMSN type II 
in oth»r types documentation of sensory nerv= 
pathology 
Abbreviation SNAPs s°nsory nerve action 
potentials 
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SAMENVATTING 
Nervus suralis-biopten van 176 patiënten (gebiopteerd tussen 1970 en 1982) 
werden retrospectief geëvalueerd. De volgende vragen stonden hierbij centraal: 
1. In hoeverre draagt de biopsie bij aan de diagnostiek en classificatie van deze 
aandoeningen3' 
2. In hoeverre draagt de biopsie bij tot nader inzicht in de pathologie en patho-
fysiologie van deze aandoeningen? 
3. Welke zijn de huidige indicaties voor het onderzoek? 
In het bestudeerde materiaal bleken er in 122 gevallen (69%) afwijkingen te 
bestaan, die evenwel slechts in 68 gevallen (39%) ook diagnostische betekenis 
hadden. De afwijkingen bestonden uit axonale degeneratie (n = 72), segmentale 
de- en remyelinisatie (n = 21), specifieke stapeling (n = 51), Lafora bodies 
(n = 10) en spheroiden (n = l ) . In 59 gevallen (34%) bestond er een klinische 
neuropathie, steeds te verklaren vanuit axonale of segmentaal de- en remyelinise-
rende veranderingen in het biopt. 
De bevindingen tonen aan c.q. bevestigen dat het degeneratie-proces in here-
dodegeneratieve aandoeningen van het centrale zenuwstelsel betrekkelijk weinig 
systeemspecifiek is, en o.a. frequent leidt tot 'meedoen' van het perifere zenuw-
stelsel, al of niet specifiek en al of niet gepaard met klinische verschijnselen op 
basis van axonale of segmentaal demyeliniserende pathologie. 
Door recente ontwikkelingen binnen de diagnostiek blijkt de betekenis van 
de biopsie voor de diagnose en classificatie van deze aandoeningen relatief gering 
geworden. De huidige indicaties zijn in principe beperkt tot patiënten met een 
duidelijk klinische neuropathie bij wie alle andere onderzoek geen diagnose 
heeft opgeleverd. 
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ADDENDUM 
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PATIENT NAME 
DATE OF BIRTH 
DATE OF BIOPSY 
DIAGNOSIS AT TIME OF REFERAI 
CLINICAL DATA 
ELECTRODI AGNOSTIC FINDINGS 
motor nerve conduction velocity 
sensory nerve action potentials 
myogram 
LABORATORY STUDIES 
SURAL NERVE BIOPSY FINDINGS 
hghtmicroscopy 
electronmicroscopv 
FOLLOW-UP DATA 
NECROPSY (if eventually performed) 
FINAL DIAGNOSIS, 
FAMILY HISTORY 
Standard registration form for summary of patient data. 
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STELLINGEN 
behorende bij het proefschrift 
"SURAL NERVE BIOPSY IN HEREDODEGENERATIVE 
DISORDERS OF THE CENTRAL NERVOUS SYSTEM" 
A. J. M. Vos Nijmegen, 3 mei 1985 
STELLINGEN 
1 Het verrichten van een perifere zenuwbiopsie is bij patiënten zonder 
klinische neuropathie doorgaans niet zinvol 
2 Bij clectroneurografie van de ncrvus surahs met behulp van oppervlak-
te-electroden is in de praktijk de antidrome methode te prefereren 
boven de orthodrome techniek 
} Na behandeling van een radiculair syndroom middels laminectomie of 
chcmonuclcohsis dient steeds een controle-EMG te worden verricht, 
dit kan interpretatieproblemen bi) recidief-klachten voorkomen 
4 Voor routine-bcdrust na lumbaalpunctie bestaat geen indicatie 
P A T Carbaat en H van Crevel Lancet 1981, π 1H3-1135 
5 Voor het gebruik van cerebrale angiografic bij het vaststellen van her­
sendood zijn geen deugdelijke argumenten aan te voeren 
6 Patienten met hardnekkige hoofdpijn en duizeligheid na cervicale dis­
torsie lopen groot gevaar in hun klachten te worden miskend 
7 Angiografic van de halsvaten is na cerebraal infarct doorgaans niet 
geïndiceerd 
8 De ontwikkeling van de ncurogeriatnc dient krachtig te worden 
gestimuleerd 


